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Abstract
Cataract is the leading cause of blindness and vision loss globally. The
implementation of artificial intelligence (AI) in the healthcare industry has been on the rise in
the past few decades and machine learning (ML) classifiers have shown to be able to
diagnose patients with cataracts. A systematic review and meta-analysis were conducted to
assess the diagnostic accuracy of these ML classifiers for cataracts currently published in the
literature. Retrieved from eight articles, the pooled sensitivity was 94.8% and the specificity
was 96.0% for adult cataracts. Additionally, an economic analysis was conducted to explore
the cost-effectiveness of implementing ML to diagnostic eye camps in rural Nepal compared
to traditional diagnostic eye camps. There was a total of 22,805 patients included in the
decision tree, and the ML-based eye camp was able to identify 31 additional cases of
cataracts, and 2546 additional cases of non-cataract.

Keywords
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Artificial intelligence, Diagnostic Accuracy, Ophthalmology, Low-to-middle income
country, Global Health
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Summary for Lay Audience
Cataract is an eye disease that many older adults get. A cataract is a buildup of
cloudiness in the human eye lens that can result in blurry and reduced vision. Fortunately,
through early and proper screening procedures, cataracts can easily be detected, and cataract
surgery can be performed to gain back vision. There has been an increasing use and
implementation of artificial intelligence (AI) in the healthcare field and machine learning
(ML) which is a subset of AI. In the field of ophthalmology, there are many developments
for the use of ML classifiers that can automatically detect eye diseases (such as cataracts) by
processing images of the eye through a computer algorithm.
In this thesis, a systematic review and meta-analysis were conducted to assess the
diagnostic accuracy of current machine learning classifiers for cataracts in both published
databases and unpublished literature. A total of 21 studies were included in the qualitative
review, and a total of nine studies were included for the quantitative analysis. From the
quantitative analysis, there was observed to be high diagnostic accuracy for identifying true
cataract cases and true non-cataract cases, these values are known as sensitivity and
specificity, respectively. For adult cataracts, there was a 94.8% sensitivity and 96.0%
specificity.
Utilizing these results from the meta-analysis, a cost-effective analysis was conducted
to test the economic feasibility of a ML cataract screening program to be implemented in a
rural region. In Nepal, rural Nepalis may have access to temporary village-level primary eye
care centres known as “diagnostic-screening and treatment camps (eye camps)”. The
objective of this second study was to conduct a cost-effectiveness analysis of the theoretical
implementation of a ML-based cataract screening eye camp in rural Nepal in order to assess
iii

if this new program is superior to the traditional eye camps. There was a total of 22,805
patients in each arm of the decision tree, and the ML-based eye camp could identify 31
additional cases of cataracts, and 2,546 additional cases of non-cataract. This suggested that
the ML-based eye camp was a more cost-effective method than the traditional eye camp in
rural Nepal.

iv

Co-Authorship Statement
Chapter 03: Diagnostic accuracy of machine learning classifiers for cataracts: a systematic
review and meta-analysis
Co-authorship: Cheung R, So S, Malvankar-Mehta MS
RC was responsible for the conceptualization of the research topic, designing and
writing the protocol, conducting the database and grey literature search, screening the
studies, conducting the risk of bias assessment, curating the data, extraction of data,
analyzing and interpreting the data, interpreting the results, writing, and editing the paper. SS
was responsible for the screening of the studies, conducting the risk of bias assessment,
curating the data, reviewing, and editing the paper. MM-M was responsible for the
conceptualization of the research topic, designing the review protocol, analyzing and
interpreting the data, validation of results, writing and editing the paper.
Chapter 04: The implementation of a machine learning-based cataract screening program
in rural Nepal: a cost-effectiveness analysis
Co-authorship: Cheung R, Li B, Thind A, Malvankar-Mehta MS
RC was responsible for the conceptualization of the research topic and the decision
tree model, cost and effectiveness data collection, data analysis and interpretation of the
study results, and writing and editing the paper. BL and AT were responsible for the
conceptualization of the research topic, interpretation of study results, revision and editing of
the paper, and gave content feedback throughout the study. MM-M was responsible for the
conceptualization of the research topic, decision tree, interpretation of study results, and
writing and editing the paper.
v

Dedication
This thesis is fully dedicated to the loving memory of my beloved little sister,
Rhonda, who I will miss and love every day.

vi

Acknowledgments
I first wanted to say thank you to the Department of Epidemiology and Biostatistics at
Western University for providing me with a wonderful education throughout my
undergraduate and master's degree. I have called this department my home for the past three
years and I am so grateful for all my amazing encounters with our faculty and staff.
I would also like to first thank my co-supervisor, Dr. Amardeep Thind, for his
constant support and engagement with my thesis. I would like to also acknowledge my
advisory committee member, Dr. Bo Li, for his insight on my thesis. They have gladly
navigated me through all the hurdles I have faced, and they have provided me with
exceptional feedback on my thesis.
I wanted to also extend a big thank you to my close friends, classmates, housemates,
and parents who have supported me. Thank you for all the discussion and encouragement
that you all have given me over the past year, and for being there when I needed it the most.
Finally, I would like to thank and give credit to Dr. Monali Malvankar for my
academic and research achievements. Dr. Malvankar is one of the most compassionate and
empathetic professors there is at Western University, and she was instrumental in the
completion of my thesis. Dr. Malvankar has always been supportive of my professional
career goals, and she has given me countless opportunities to conduct research and develop
my professional skills.

vii

Table of Contents
Abstract ............................................................................................................................... ii
Keywords ............................................................................................................................ ii
Summary for Lay Audience ............................................................................................... iii
Co-Authorship Statement.................................................................................................... v
Dedication .......................................................................................................................... vi
Acknowledgments............................................................................................................. vii
Table of Contents ............................................................................................................. viii
List of Tables .................................................................................................................... xii
List of Figures .................................................................................................................. xiii
List of Appendices ........................................................................................................... xiv
List of Abbreviations ........................................................................................................ xv
CHAPTER 1 ....................................................................................................................... 1
1 Introduction .................................................................................................................... 2
1.1 Structure of thesis ................................................................................................... 3
1.2 References ............................................................................................................... 4
CHAPTER 2 ....................................................................................................................... 7
2 Literature Review, Thesis Rationale, and Thesis Objectives ......................................... 8
2.1 Literature Review.................................................................................................... 8
2.1.1

Natural History of Cataracts ....................................................................... 8

2.1.2

Risk Factors ................................................................................................ 9

2.1.3

Epidemiology of cataracts......................................................................... 12

2.1.4

Clinical Assessment of Cataracts .............................................................. 13

2.1.5

Artificial Intelligence in Healthcare.......................................................... 20

2.1.6

AI and ML in Ophthalmology .................................................................. 22
viii

2.1.7

Thesis Methodologies ............................................................................... 25

2.1.8

Conclusion ................................................................................................ 36

2.2 Thesis Rationale .................................................................................................... 37
2.3 Thesis Objectives .................................................................................................. 39
2.4 References ............................................................................................................. 40
2.5 Table ..................................................................................................................... 53
CHAPTER 3 ..................................................................................................................... 55
3 Diagnostic Accuracy of Machine Learning Classifiers for Cataracts: A Systematic
Review and Meta-analysis ........................................................................................... 56
3.1 Introduction ........................................................................................................... 56
3.1.1

Background ............................................................................................... 56

3.1.2

Objective ................................................................................................... 57

3.2 Methods................................................................................................................. 58
3.2.1

Search Strategy ......................................................................................... 58

3.2.2

Inclusion and Exclusion Criteria ............................................................... 59

3.2.3

Screening................................................................................................... 60

3.2.4

Risk of Bias Assessment and Data Extraction .......................................... 61

3.2.5

Statistical Analysis .................................................................................... 62

3.3 Results ................................................................................................................... 63
3.3.1

Search Results and Study Characteristics ................................................. 63

3.3.2

Risk of Bias Assessment ........................................................................... 65

3.3.3

Diagnostic Accuracy of Machine Learning Classifiers for Cataracts in
Adults ........................................................................................................ 65

3.3.4

Diagnostic Accuracy of Machine Learning Classifiers for Pediatric
Cataracts .................................................................................................... 67

3.4 Discussion and Conclusion ................................................................................... 68
3.5 References ............................................................................................................. 71
ix

3.6 Tables and Figures ................................................................................................ 78
CHAPTER 4 ..................................................................................................................... 87
4 The Implementation of a Machine Learning-Based Cataract Screening Program in
Rural Nepal: A Cost-Effectiveness Analysis ............................................................... 88
4.1 Introduction ........................................................................................................... 88
4.1.1

Objective ................................................................................................... 91

4.2 Methods................................................................................................................. 91
4.2.1

Study Setting and Population .................................................................... 91

4.2.2

Model Design ............................................................................................ 92

4.2.3

Interventions ............................................................................................. 93

4.2.4

Model Probabilities and Cost Data ........................................................... 94

4.2.5

Effectiveness Measures ............................................................................. 96

4.2.6

Deterministic Sensitivity Analysis............................................................ 97

4.3 Results ................................................................................................................... 97
4.3.1

Base-case Analysis.................................................................................... 97

4.3.2

Sensitivity Analysis .................................................................................. 98

4.4 Discussion and Conclusion ................................................................................. 100
4.5 References ........................................................................................................... 104
4.6 Tables and Figures .............................................................................................. 110
CHAPTER 5 ................................................................................................................... 117
5 Integrated Discussion ................................................................................................. 118
5.1 Overview ............................................................................................................. 118
5.2 Integrated Discussion of Results ......................................................................... 118
5.3 Thesis Limitations............................................................................................... 120
5.3.1

Limitations in Chapter 03 ....................................................................... 120

5.3.2

Limitations in Chapter 04 ....................................................................... 121
x

5.3.3

Limitations in the Applications of Artificial Intelligence ....................... 122

5.4 Conclusions and Future Directions ..................................................................... 124
5.5 References ........................................................................................................... 125
APPENDICES ................................................................................................................ 129
CURRICULUM VITAE ................................................................................................. 146

xi

List of Tables
Table 2.1 Ophthalmic evaluation for the diagnosis and treatment of cataract. (Table adapted
from the Canadian Ophthalmological Society)34 .................................................................... 53
Table 2.2 Possible results from a cost-effectiveness analysis – dominance chart .................. 54
Table 3.1 Study characteristics of the included studies .......................................................... 79
Table 4.1 Base case model parameters and parameter ranges .............................................. 110
Table 4.2 Estimated costs for traditional eye camps and ML-based eye camps................... 111
Table 4.3 Diagnostic test outcomes of traditional eye camps and ML-based eye camps per
22,805 patients in the study model ....................................................................................... 112
Table 4.4 Incremental cost-effectiveness results for traditional eye camps vs ML-based eye
camp ...................................................................................................................................... 112
Table 4.5 One-way deterministic sensitivity analysis results ............................................... 113

xii

List of Figures
Figure 3.1 PRISMA flow diagram showing the study selection process and reasons for
exclusion ................................................................................................................................. 83
Figure 3.2 Hierarchical summary receiver operating characteristic plot for cataracts in adults
................................................................................................................................................. 84
Figure 3.3 Forest plot of the pooled sensitivity and specificity estimates for the ML
classifiers for cataracts in adults ............................................................................................. 85
Figure 3.4 Hierarchical summary receiver operating characteristic plot for pediatric cataracts
................................................................................................................................................. 86
Figure 3.5 Forest plot of the pooled sensitivity and specificity estimates for ML classifiers for
pediatric cataracts.................................................................................................................... 86
Figure 4.1 Decision tree showing the competing alternatives for cataract diagnosis and
screening camps. Arm 1 illustrates the traditional eye camps; Arm 2 illustrates to the MLbased eye camps evaluated in the model. A square represents a decision node, a circle is a
chance node, and the triangle represents the terminal node.................................................. 114
Figure 4.2 Cost-effectiveness plane of traditional eye camps vs introduction of ML-based eye
camps. The traditional eye camp program is absolutely dominated by the ML-based eye
camps. ................................................................................................................................... 115
Figure 4.3 Tornado diagram of the one-way deterministic sensitivity analysis with critical
variables. The vertical line represents the final ICER (-0.475). All the variables crossed the
final ICER value which demonstrates that none of the parameters disturbs the final result
from the base-case................................................................................................................. 116

xiii

List of Appendices
Appendix A: PRISMA Checklist .......................................................................................... 129
Appendix B: Database searches and keywords .................................................................... 131
Appendix C. Search strategy and results for grey literature ................................................. 131
Appendix D. Kappa statistics calculation ............................................................................. 132
Appendix E. Simplified data extraction table ....................................................................... 134
Appendix F. Results of the risk of bias assessment for studies included in the systematic
review using QUADAS-2 Tool ............................................................................................ 136
Appendix G. SROC Curve.................................................................................................... 137
Appendix H. Hierarchical logistic regression results ........................................................... 138
Appendix I: CHEERS Checklist ........................................................................................... 140
Appendix J: Base model variable inputs and definitions ...................................................... 143
Appendix K: Two-way sensitivity analysis .......................................................................... 144
Appendix L: Multi-way sensitivity analysis ......................................................................... 145

xiv

List of Abbreviations
AI

Artificial intelligence

ARDA

Automated Retinal Disease Assessment

CCPCMOH

Childhood Cataract Program of Chinese Ministry of Health

CBA

Cost-benefit analysis

CEA

Cost-effectiveness analysis

CUA

Cost-utility analysis

CHEERS

Consolidated Health Economic Evaluation Reporting Standards

CNN

Convolutional neural network

DALY

Disability-adjusted life years

DLS

Deep learning system

DOR

Diagnostic odds ratio

DR

Diabetic retinopathy

fn

False negative

fp

False positive

HSROC

Hierarchical summary receiver operating characteristic

ICER

Incremental cost-effectiveness ratio

IOP

Intraocular pressure

LMIC

Low-to-middle income country

LOCS

Lens opacity classification system

LR

Likelihood ratio

LY

Life years

MeSH

Medical Subject Headings

ML

Machine learning

OA

Ophthalmic assistants

OHIP

Ontario Health Insurance Plan

OOP

Out-of-pocket

OT

Ophthalmic technicians

PRISMA

Preferred Reporting Items for Systematic Reviews and Meta-Analyses

PSA

Probabilistic sensitivity analysis

QALY

Quality-adjusted life years

QUADAS

Quality of diagnostic accuracy studies

SROC

Summary receiver operating characteristic

SVM

Support vector machine

tn

True negative

tp

True positive

UV

Ultra-violet

WHO

World Health Organization

WTP

Willingness-to-pay
xv

1

CHAPTER 1

2

1

Introduction
According to a report by the World Health Organization (WHO) in 2010, cataracts

account for approximate 50% of the world’s first cause of blindness.1,2 In fact, the rate and
prevalence of cataracts globally and nationally is on the rise due to the world’s aging
population, thus making cataracts a health priority and a disease of concern for health and
aging. 3–5 There are significant social and economic costs associated with vision loss for both
the patient population and the healthcare system, and new technologies are emerging to help
meet the high patient demands.1,6
Within the field of ophthalmology, the rise of artificial intelligence (AI) and machine
learning (ML) has grown substantially in the past decade.6,7 Many novel algorithms and
applications of AI are currently being used in routine clinical practice that aid
ophthalmologists and healthcare practitioners with the diagnosis and grading of certain eye
diseases. Various technology companies, such as Google and IBM, have invested in the
growth and development of machine learning in ophthalmology, and most of the research has
been conducted on diabetic retinopathy (DR).8 The success of these technologies has given
the potential and hope for researchers to apply similar techniques to other common eye
diseases such as glaucoma, age-related macular degeneration, and cataracts.9–11
For cataracts specifically, research in the use of AI and ML has shown the potential
for these algorithms to be used for multiple purposes throughout the course of a patient’s
cataracts diagnosis to cataracts treatment. Mainly, ML classifiers have been used to screen
cataracts through training and validating fundus or slit-lamp eye images to provide a fast and
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accurate diagnosis.12–14 Additionally, AI-based methods have also been used to create
intraocular lens power calculations as part of the cataracts surgery process to determine a
predictive error post-cataracts surgery.15,16 However, there are gaps in the literature on the
aggregated diagnostic accuracy of these ML diagnostic programs, and its cost-effectiveness
compared to in-person screening procedures. High diagnostic accuracy is important, but cost
is also a substantial part of the decision-making process if these algorithms are to be
routinely implemented in hospital settings, ophthalmology clinics, or rural diagnostic and
screening eye camps. It is important to assess the current literature and body of evidence on
cataracts, the cataracts screening and diagnosis process, and the applications of AI or ML in
cataracts care and management.

1.1 Structure of thesis
This thesis is written in the integrated article format within the standards of Western
University School of Graduate and Postdoctoral studies. Chapter 02 is a literature review on
the background and current knowledge of cataracts, and machine learning applications in
healthcare and ophthalmology. The literature review also discusses the methodology of a
systematic review and meta-analysis used in Chapter 03 and the methodology of a costeffectiveness analysis used in Chapter 04. Chapter 02 also includes the thesis rationale and
objectives.
The thesis consists of two manuscripts. Chapter 03 is comprised of the first
manuscript titled “The diagnostic accuracy of machine learning classifiers for cataracts: a
systematic review and meta-analysis”. Chapter 04 is comprised of the second manuscript
titled “The implementation of a machine learning-based cataract screening program in rural
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Nepal: a cost-effectiveness analysis”. Chapter 05 includes an integrated discussion of the
results of the thesis.
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2

Literature Review, Thesis Rationale, and Thesis Objectives

2.1 Literature Review
2.1.1 Natural History of Cataracts
A cataract is the opacification of the lens in the human eye which results in poor
visual acuity and transparency. 1 Cataract can occur in one eye or both eyes.1 The opacity of
the lens is caused by oxidative stress, and it primarily affects the growth and development of
the lens epithelial cells.2 The lens is located positionally behind the iris and in front of the
vitreous body and retina. The lens helps focus light into the eye to produce sharp images, but
as the cataract develops, it blocks the light passing through the lens and prevents a sharp
image from reaching the retina.1 As a result of the cataracts, the patient loses optical clarity
and has a clouded vision.1,3
Symptoms
Common symptoms that patients with cataracts experience can include clouded,
blurred, or dimmed vision.3 A visual decline that can span over weeks, months, or years.
Patients may be sensitive to light and glare, and halos can form around lights.1,4,5
Additionally, changed experience in vision can result in the yellowing of images and
decreased colour intensity. Corrective glasses do not help improve eyesight if the cataract is
left untreated.
Classification of Cataracts
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Cataracts is often categorized by their cause-types which include age-related
cataracts, congenital cataracts, and cataracts secondary to other causes.3,5,6 First, age-related
cataracts can be divided into three types: nuclear, cortical, and posterior subcapsular.1 Often,
patients can present with just one type or a combination of types of age-related cataracts.
Nuclear cataract occurs when new fiber layers from the lens epithelial cells migrate towards
the lens equator, and the lens nucleus becomes compressed (nuclear sclerosis) which creates
an opacification. Cortical cataract starts at the cortex of the lens where cortical spokes can
develop and cause discrete opacities.7 Cortical cataract can be located posteriorly or
anteriorly of the lens, and it is often wedged-shaped.8 Posterior subcapsular cataract is in the
axial posterior cortex where plaques and deposits develop.1,9,10
In addition to age-related cataracts which are the most common, pediatric cataracts is
also prevalent in infant populations. In congenital cataracts, the lens opacity would have been
present at birth, but then manifested and developed within one year of the infant’s life.11
Approximately one-third of patients with pediatric cataracts are due to inheritance. Pediatric
cataracts can be classified as unilateral or bilateral cataracts.12

2.1.2 Risk Factors
Cataractogenesis – meaning the process of cataract formation – may be caused and
influenced by a multitude of risk factors. The current evidence of other direct risk factors for
cataracts can range from limited to strong evidence. These risk factors can be modifiable or
non-modifiable.9,13,14
Non-Modifiable Risk Factors
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Age - The most common form of the development of cataracts is age-related, which
makes this a disease a priority in the health and aging context.1 The onset of cataracts often
begins at the age of 45-50 years because of oxidative stress, solubilization, and cross linking
by the lens fibers.2 There is conclusive evidence that age is a personal risk factor for nuclear,
cortical, and posterior subcapsular cataract.
Sex - Many studies have shown that females are at a greater risk for cataracts than
males, and females experience a higher cataract burden.15
Genetics - Genetic effects are important and contributing factors to the development
of cortical cataracts. Genetic modelling suggests that additive and dominant genes can
suggest the causation of cortical cataracts based on the Twin Eye Study.16 Additionally,
genetic factors can account for up to 50% of the variation in severity in nuclear cataract
cases.
Modifiable Risk Factors
Diabetes - Patients with diabetes have an increased risk for developing cataracts.
There is increased risk specifically for cortical and posterior subcapsular cataracts, but there
is no significant association with nuclear sclerosis.17 Increased glucose levels in the lens are
converted into sorbitol which can cause the lens to be opaquer and cloudier. Additionally,
non-enzymatic damage to the lens protein (glycation) may be involved in the development of
cataracts.3
Alcohol intake - Strong evidence of increased risk for cataracts is found for
individuals who are heavy drinkers. In a meta-analysis conducted by Gong et al., heavy
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alcohol consumption significantly increases the risk of age-related cataracts, though
moderate consumption of alcohol has been revealed to have some protective effects against
cataracts.18 Heavy alcohol consumption was defined as consuming more than 20g of alcohol
in a day.
Trauma - Direct, blunt trauma to the eye is another cause of cataracts due to damaged
lens fibres.3 Blunt trauma can cause the eye to swell, and fibres in the lens to thicken which
causes increased opacity. Other sources of traumatic cataracts can be due to infrared lights,
electric sparks, or head injuries.9,19
Hypertension - A meta-analysis by Yu et al. found that high blood pressure can
increase the risk of cataracts by 8-28%.20 Studies have suggested that the link between
hypertension and cataract development is in part due to anti-hypertension medications that
can disturb electrolyte balance around the lens fiber membrane. Additionally, hypertension
may also cause lens capsules to have conformational changes which interferes with
potassium ion transport.21,22
Ultra-violet (UV) ray exposure - Another risk factor for cataracts is exposure to UV
rays over time. UV light can damage lens proteins and cells in the lens, and it can continue to
be damaged by oxidative stress. The Canadian Ophthalmological Society recommends that
people and children at a young age should get into the habit of wearing sunglasses as
preventative measures.23
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Toxins and chemicals in smoke can increase the risk of cataract development and
increase opacities are reported. There is an increased odds of 1.41 for nuclear cataracts with
individuals who have smoked in their life.24
In pediatric cataracts, there is also a plethora of reasons for the development of
cataracts in infants. As noted previously, the main driver of pediatric cataracts is due to
hereditary factors and the inheritance of genetic factors that cause the opacification of the
lens. 11 However, this claim is still scarcely researched, even if it is the commonly agreed
stance.

2.1.3 Epidemiology of cataracts
Global Epidemiology
According to the WHO, there are at least 2.2 billion people in the world who
experience near or distance impaired vision, and 94 million of those cases are as a result of
cataracts.25,26 More than 50% of the world’s first cause of blindness is due to cataracts and it
is the leading cause of blindness. Based on a meta-analysis by Hashemi et al., the pooled
prevalence estimate of any cataracts is approximately 17.20% in the world, with nuclear
cataract leading with a prevalence of 8.22%, and cortical cataract with 8.05%.27 Hashemi et
al. also found the pooled prevalence estimate of cataracts in females and males was around
the same, with females at 33.67%, and males at 32.57%. The authors noted the geographic
location (based on the six WHO regions) that had the highest prevalence of cataract was the
South-East Asia region, followed by the Western Pacific, and Europe.27
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Globally, cataract has contributed to 17.7 million disability-adjusted life years
(DALY) in adult populations. DALY is a common metric to describe the total number of
years lost to disability or premature death.28 In Southeast Asia alone, the global health burden
of cataract vision loss was approximately 125 disability-adjusted life years (DALYs) per
100,000 people — the highest crude DALY rate out of all WHO regions.29,30 Unfortunately,
the DALYs are expected to increase for the cataract population due to the world’s aging
population, and lack of access to early care. Many people who live in rural or underserviced
areas often receive a delayed cataract diagnosis or lack the facilities to receive cataracts
surgery, which leads to blindness (a measure of disability).
While cataract is commonly found in adult and elderly patients, pediatric cataract has
an estimated prevalence of 4.24 per 10,000 live births, and it is the major causes of childhood
blindness.31

2.1.4 Clinical Assessment of Cataracts
An early diagnosis of cataracts is often ideal because preventative measures can be
immediately taken to delay and slow down the deterioration of vision.32,33 Correction glasses,
anti-glare glasses, or magnifying lenses can be used when cataracts begin to interrupt daily
activities before surgical intervention is needed. The standards for the cataract screening
procedure with an optometrist or an ophthalmologist will vary based on location due to
government policies, insurance coverage, economic status, healthcare costs, and access to
care.6,34 Many factors influence the thoroughness and completeness of an eye examination
depending on the availability and demand of such services. The clinical assessment and
process of examining a patient’s eye in a high-income country will be very different than a
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patient living in a rural or low-to-middle income country (LMIC) due to the scarcity of
resources and trained personnel.35,36
The Canadian Ophthalmological Society has published clinical practice guidelines for
cataracts surgery which also outlines the suggested ophthalmic evaluation for the diagnosis
of cataract.34 The guidelines for Ontario will be used to illustrate the full procedure of an eye
examination for cataracts, although it may be not fully feasible in other under-serviced
regions. It is noted that there is no single test or examination that adequately describes the
effect that the cataract has on the patient’s visual status and functioning ability.33
In Ontario, Canada, the Ontario Government has published a “Quality-Based
Procedures Clinical Handbook: Cataract Day Surgery” which provides guidelines and
standards that healthcare professions are to follow in the cataract setting.37 As part of the
assessment and referral pathway in the handbook, annual eye exams should be performed in
individuals who are over the age of 65, and anyone with current conditions of diabetes,
glaucoma risk, or other eye conditions. It is important note that although everyone should
receive annual exams, the current Ontario Health Insurance Plan (OHIP) only insures annual
eye exams for people younger than 20 or over 65, if they have one or more ocular conditions,
or if their primary healthcare provider necessitates an annual exam.37 This public insurance
coverage is found to be similar in other provinces in Canada, though not all.
To diagnose a patient with cataracts, the ophthalmologist will ask about the patient’s
medical history and any symptoms that they are experiencing. A patient’s assessment will
include their current medications and medical conditions, previous ophthalmic surgery, and
risk factors that can affect the surgical plan.6,32,38 Additionally, an eye examination should be
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conducted by an ophthalmologist, primary care physician, or optometrist. A complete eye
exam should include a visual acuity test, slit lamp imaging exam, dilated eye exam, and a
tonometry.6,34,37,39 The full ophthalmic evaluation for the diagnosis and treatment of cataract
is displayed in Table 2.1.34
Visual acuity tests
Visual acuity tests are used to test the patient’s ability to discern shapes and details in
their vision and to rate the patient’s recognition of small details with precision. Eye charts —
also known as optotypes — are used to test for visual acuity. If the patient is unable to read
the eye charts at any distances, alternatives to the visual acuity test include counting fingers,
hand motion, and light perception tests.40
Most commonly, the Snellen chart is used for visual acuity tests, and it is widely used
at the clinical level. It is especially commonly used for patients with myopia, hyperopia, or
astigmatism, and for assessing vision problems in young children.41,42 The Snellen chart is a
simple and effective way for physicians, ophthalmologists, or optometrists to recognize signs
of vision loss and diagnosis of cataracts because it also considers the patient’s perspective for
their visual function.42,43 The Snellen chart is a multi-letter chart with a variation in number
of letters on each line of the chart; this presents the examinee with increasing difficulty to
identify the letters. The examinee typically reads the chart 6 meters (20 feet) away, testing
one eye at a time.42,43 The common term “20/20 vision” or “6/6 vision” refers to the patient’s
ability to see clearly at 20 feet what should normally be seen at that distance.42
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Despite the Snellen chart’s ease and universal use, its limitations include the lack of
reproducibility and reliability in its results.41 There have been articles that criticizes the
Snellen chart’s failure to test visual acuity at the right distance and under the recommended
levels of illumination. As a result, newer charts such as the logMAR (logarithm of the
minimum angle of resolution) became available to negate the disadvantages of the Snellen
chart.44,45 The logMAR chart has letters that are of equal legibility, with the same number of
letters on each row and uniform letter and row spacing. There is a logarithmic progression in
the letter size which ensures test task standardization. The logMAR chart is less used in
clinical practice, though it has become the standard in research settings.
Slit-lamp biomicroscope imaging
Slit-lamp imaging is an important element of the eye examination because it captures
physical elements of the eye that a visual acuity test cannot determine. Slit-lamp imaging
must be done because the ophthalmologist needs to rule out other ocular diseases before
diagnosing cataracts and suggesting cataract surgery. Slit-lamp microscopes get their name
from the thin sheet of high-intensity light source that focuses and shines into the eye.32,34 Slitlamp microscopes are able see the details of the transparent, translucent, and opaque
structures of the anterior and posterior segment of the human eye. Slit-lamp microscopes uses
a variety of magnifications and angles to observe the patients and ophthalmologists can
decide the type of cataracts based on what is exhibited in the lens.34 In most patients,
ophthalmologists can determine if cataracts are responsible for the patient’s visual loss by
comparing the slit lamp images with the patient’s symptoms.
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The slit lamp can see what is manifested in the anterior segments of the eye, and
examine the lens, vitreous, macula, peripheral retina, and optic nerve through a dilated pupil.
For example, cortical cataracts can be diagnosed by observing the formation of vacuoles,
clefts, wedges, or lamellar separations.
Tonometry Test
A tonometry test is a procedure to determine the intraocular pressure (IOP) inside the
eye.46 IOP is the fluid pressure of the eye, and it is formed from the balance between aqueous
humour formation and outflow on the internal surface area of the anterior eye. The
Goldmann applanation tonometry, using the Goldmann equation, is the most used method in
the clinical setting. The Goldmann equation uses the aqueous flow rate, aqueous outflow, and
episcleral nervous pressure to measure the change in the IOP.47 This method uses a flattipped probe that presses against the surface of the eye; however, other types of methods are
available called non-contact tonometry that uses air pressure.47,48 Pressures between 11 and
21 mmHG are generally considered to be normal. A tonometry test is important in a full
ocular examination because an elevated IOP is an indicator for glaucoma. By identifying the
IOP, ophthalmologists or optometrists can confirm or rule out glaucoma.
Cataract classification systems
Currently, there are several systems that are commonly used to classify and grade lens
opacities. Grading systems are important for clinical and research use, and for the
communication between patient and physician.49 However, the variation in classification
systems makes it very difficult for comparative studies to be performed due to the slightly
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differing definitions and grading systems that are being used. In 1989, West and Taylor
called for a standardized method of grading and classifying cataracts, thus the Oxford
Clinical Grading System and the early versions of the Lens Opacity Classification System
(LOCS) were created.50,51 Since then, these grading and classification systems have evolved.
There are updated versions of the LOCS (LOCS II, and LOCS III) and other grading systems
that have emerged including the Johns Hopkins system, and the Wisconsin Cataract Grading
System.52 However, it is noted that the cataract classification system varies from country to
country, often influenced by insurance coverage, and health priorities of the country.
In these grading systems, the following elements are considered: anterior clear zone
thickness, anterior subcapsular opacity, posterior subcapsular opacity, cortical spoke opacity,
water clefts, vacuoles, retro-dots, focal dots, nuclear brunescence and white nuclear
scatter.50,53 The LOCS III was updated in 1993 in order to better capture an early cataracts
diagnosis by observing nuclear opalescence and nuclear colour on a scale from 1 to 6,
cortical cataracts on a scale from 1 to 5, and posterior subcapsular cataracts on a scale from 1
to 5.50, 53
Clinical Assessment of Cataracts in Rural and Low-to-Middle Income Countries
In rural regions, villages, and LMIC, most people do not have the ability or luxury to
seek out an eye care provider regularly because the closest eye care centres are in semiurban
or urban areas which may be geographically far away from the villages, people may have to
pay out of pocket for the healthcare services, and people may be unaware of such
services.36,54
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Additionally, the optometrist and ophthalmologist to general population ratio may be
very low and below the standards set by WHO. For example, in Nepal, the ophthalmologist
to population ratio is approximately 1:193,900, and 1:791,700 for optometrists.36 The
recommendation set out by WHO is 1:100,000 for both ophthalmologists and optometrists.25
To remedy many of these concerns in both Nepal, India and other LMICs, temporary villagelevel primary eye care centres called “eye camps” have been implemented in the past few
decades to reach to these rural patients.35,55 The goal of these eye camps is to eliminate any
financial or geographical barriers that many rural patients may have to access their health
services in more semiurban settings.
These make-shift and temporary eye camps often employ only ophthalmic assistants,
ophthalmic technicians, and/or nurses to operate the eye camps, and very minimal
ophthalmic equipment is available for these workers.56,57 An ophthalmic assistant often
conducts the assessment and makes clinical decisions in replacement of an ophthalmologist
or optometrist. Therefore, it is not feasible to conduct a full eye examination (as they do by
standard in Ontario, Canada) in these eye camps, but rather a simplified process that may
include a Snellen chart, a slit-lamp microscope, a pen light, and/or a portable
ophthalmoscope.58 When a rural patient is given a diagnosis of any grade and/or
classification of cataract in diagnostic eye camps, they are automatically given a referral to an
ophthalmologist.35 Typically, in the Ontario and Westernized context, a patient may have
multiple follow-up appointments with an optometrist or eye specialist over a period before a
referral to an ophthalmologist is given.34
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2.1.5 Artificial Intelligence in Healthcare
The use of AI has revolutionized the way that healthcare can be provided to patients
in these rural areas, and it has greatly supported the efforts and developments of telemedicine and more specifically, tele-ophthalmology.
Evolution of AI healthcare
AI is a branch of computer science that aims to simulate a human’s mental process
through software programs and learn to solve problems similarly to the human brain.59 The
use of AI has been on the rise in health care and biomedical research in the past decade.
Substantive progress in this field of research has been made as healthcare providers, policy
makers, and researchers because of the potential for its use in standard practice.59–61
However, AI is not a completely new technology that has only recently existed. In fact, AI
has been used in healthcare in the 1970s in the form of rule-based approaches. This early
application of AI was used to interpret electrocardiograms, diagnose certain diseases, and
provide simple clinical reasoning and interpretations for hypothesis generation.60 However,
the performance of these systems was limited by their lack of comprehensive medical
knowledge, and it required humans to be involved in every decision step. Despite the
inefficiencies of the early AI technologies, they provided progress towards a fully
autonomous system.60
The healthcare sector has benefited from the emergence of AI because the increasing
availability of healthcare data has made it possible for AI to flourish in this sector. Large
amounts of healthcare data can be used in AI algorithms to assist in making clinical decisions
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that can be cost and time efficient. AI is not intended to replace human physicians or
healthcare providers, but to assist in clinical decisions and replace human judgement in
certain areas of healthcare.59 Ideally, the ultimate goal for AI processes is to have a fully
automated clinical system to make decisions and output results, but as these technologies are
still emerging, AI can exist in the healthcare setting through conventional decision support
systems, or integrative decision support systems.59,61–63
AI research areas in the current literature are mostly done in the field of diagnostic
imaging, genetics, electrodiagnosis, and physiologic monitoring.59,61 The leading disease
types that have the most research conducted in AI in the literature are neoplasms, nervous
system, cardiovascular, and urogenital. Since the 2010s, there has been a stark increase in the
number of publications with the AI keyword in the databases.59 In the past decade, the use
and application of AI algorithms have spanned across a plethora of disciplines and fields,
notably in ophthalmology.
Since the utilization and implementation of AI in healthcare is still relatively new,
there continues to be many ethical and legal concerns surrounding its practice. There exist
many issues regarding data privacy, data and algorithm bias that exists in AI which are
debated by policy makers and researchers.64,65 These concerns are further addressed in the
integrated discussion (Chapter 05).
Machine Learning
Machine learning (ML) is a sub-set of AI which describes the use of computer
algorithms to learn and identify patterns in the data. Through training and validation, these
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ML algorithms be given large amounts of healthcare data to perform a specific task.60 There
exist many types of ML algorithms that are regularly used in healthcare applications
including support vector machines (SVM), neural networks, logistic regression, random
forests, and others. 60 SVM and neural networks are the two most researched and used
algorithms.

2.1.6 AI and ML in Ophthalmology
Specifically in the field of ophthalmology, vast amounts of AI research have been
conducted by Google Inc for diabetic retinopathy (DR).66 The Google Health team has
developed a DR screening solution in which the team recruited a large team of
ophthalmologists to screen through 100,000 retinal scans in order to train their AI
algorithm.66,67 In their study conducted by Gulshan et al., the Google Health research team
was able to train and validate an algorithm that had a 98.1% specific and 98% specificity for
detecting referable DR.67 The purpose of this project was to create an AI-based application
called the Automated Retinal Disease Assessment (ARDA) to assist clinicians and physicians
to screen through retinal images in lower-to-middle income countries (LMIC) such as
Thailand and Nepal. The ARDA screening program allows the user to upload a fundus image
to the platform, and the application can give an instant analysis of diabetic retinopathy.67 In a
matter of seconds, the algorithm can identify if DR exists in the image and the grade of the
DR. The rise of this study gave potential to many researchers within the ophthalmology field
to explore the use of AI in diagnosis and other aspects of healthcare delivery.68,69
There have been numerous systematic reviews and meta-analyses that have
investigated the use of ML classifiers for diagnoses in different eye diseases. In a meta-
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analysis by Cheung et al. that included 13 studies, they found that ML classifiers were able to
detect age-related macular degeneration with a 91.8% sensitivity, and 88.8% specificity.70 In
another meta-analysis conducted by Murtagh et al., the researchers assessed the accuracy of
ML screening for glaucoma.71 Similarly to Cheung et al., they found high accuracy for the
screening program with an area under the ROC (AUROC) value of 0.957 for fundal photos,
and 0.923 for OCT images.71 Evidently, there is a lot of research conducted in diagnostic
imaging, proving screening programs like ARDA can be translated to other eye diseases.
The use of AI and ML have demonstrated effective use for offering diagnosis services
to individuals in under-developed, under-serviced, and remote areas.72 For patients in these
regions such as Indigenous communities where there are limited ocular specialists, the use of
AI can provide patients with a quick and cost-effective diagnosis. An ophthalmic technician
or a general practitioner can take an image of the patient’s eye and diagnose the patient using
the AI screening program.72,73 This method of healthcare delivery prevents the need of
patients to travel long distances to visit an ophthalmologist, and the patient is able to receive
an early diagnosis. The healthcare sector benefits from this process due to reduced wait times
that may exist in clinics, reduced travel times, and increased specialist referral rates.
Additionally, in the field of ophthalmology, there exists high occupational burnout
among ophthalmologists.74 Due to the increase in our aging population, there will inevitably
be an increase in people with eye diseases such as glaucoma, cataracts, and AMD.75 The
workload of ophthalmologists will need to increase in order to accommodate these patient
demands. In the conventional method of ophthalmologists diagnosing every patient, this
process can be very time consuming and expensive. There will be continual pressures faced
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by ophthalmologists to keep up with the influx of patients. Thus, novel methods such as the
implementation of AI should be implemented in the workplace to assist clinicians.
Machine Learning Classifiers for Cataract Diagnosis
In the last decade, research teams around the world have researched the use of ML
classifiers to automatically diagnosis and screen for cataracts. There have been studies
published on this research since 2009 and new studies published in 2021.63 Acharya et al.
published their study in 2009 based in India, and the research uses a backpropagation neural
network as their ML classifier.69 As newer studies were published, there was a general trend
of an increase in images used to train and validate the ML algorithms. This may be due to the
increasing advancement of ML algorithms, coding, and infrastructure of the neural networks.
In Wu et al., a total of 37,638 slit-lamp images were used to train and validate, and a
convolutional neural network (CNN) was used in the study.76 With their CNN, they were
able to accurately diagnose cataracts with a 92.0% sensitivity, and 83.9% specificity.
There is a gap in current literature for a meta-analysis on the diagnostic accuracy of
all ML classifiers for diagnosing cataracts. This type of study is needed to show the potential
of ML classifiers for an accurate diagnosis so these technologies can be implemented in
regular clinical settings. If the existing ML classifiers prove to be inaccurate with a low
pooled sensitivity and specificity, then it informs researchers and computer scientists to
develop better models and algorithms for cataract diagnosis.62
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2.1.7 Thesis Methodologies
This thesis will contain two studies (Chapter 03 and Chapter 04) that will use
different methodologies. Chapter 03 will contain a systematic review and meta-analysis that
will summarize the current literature on the diagnostic accuracy of machine learning
classifiers for cataracts. Chapter 04 will contain a cost-effectiveness analysis using the results
found from Chapter 03.
Systematic Review
A systematic review is a type of literature review that synthesizes all available
scientific evidence with a specific methodology that limits bias on a certain topic.77
Systematic reviews are a form of evidence synthesis that are reproducible and transparent in
its methods and have a focused and well-defined research question – these are some elements
that distinctly separates a systematic review from a narrative review.77 Systematic reviews
are important because it is an evidence-based practice that uses the best available evidence in
both published and grey literature. Systematic reviews are especially useful for policy
makers, healthcare personnel, and researchers because it summarizes and collates all
available literature on a research topic into one document.77 This type of review makes it
very easy for individuals to be thoroughly informed on one research topic and make
evidence-based decisions. This form of review increases the precision of result estimates by
minimizing bias in the review, and it also judges the quality of the evidence included in the
study.
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Systematic reviews need to follow the PRISMA checklist which is a standardized
process.78 The process of a systematic review begins with developing a strong and welldefined research question. This is important to the review because a clear and strong
objective will guide the researcher to developing useful results and analysis.77,79 Next, a
comprehensive database search of published literature must be conducted to obtain relevant
literature related to the research question.77 Keywords and MeSH terms should be formulated
by the research team in order to yield the most relevant results for the selected database
search. Additional searches consist of forward and backward citation tracing, manual
searching, and grey literature through conference proceedings and unpublished literature.
After retrieving all relevant literature, the study will go through study screening where the
reviewers will do a multi-level title, abstract, and full-text screening. If the reviewers do not
agree on an article’s eligibility towards the study inclusion criteria, then the reviewers may
resolve conflicts with one another, or a third reviewer will step in and decide.
The studies that have been included after the full-text review will then go through a
risk of bias assessment to assess the bias and quality of the individual studies included.77,79
There are many different types of risk assessments for different study types (ie. intervention
studies, observational studies, diagnostic accuracy studies, etc.) which rates the individual
studies. For diagnostic accuracy studies, the QUADAS-2 Tool is the most used assessment to
assess each included study.80 After the risk of bias assessment, the finalized studies can go
through data extraction where relevant study information such as study population, design,
objectives, and results can be collected.77
Meta-analysis
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Meta-analysis is a form of statistical analysis that uses different techniques to pool
and summarize data from different studies on a similar topic.81,82 When conducting a
systematic review, the authors may additionally conduct a meta-analysis if the retrieved and
included studies contain a consistent effect size across the studies to compute a summary
effect. Effect size is a unit of currency in a meta-analysis, and it is a measure in a study that
represents the impact of an intervention in a study.82 An effect size can represent any
relationship between two variables in a study, or it can be an estimate of a single value.
Effect sizes can be dichotomous (ie. Risk ratios, odds ratios, log ratios), continuous (ie. mean
differences, response ratios), or correlational; analysis can be made with many types of
data.82
Meta-analyses are especially powerful when summarizing and quantifying effect
sizes because each study included in the meta-analysis is given a different weight in the
analysis. Studies with greater precision in its results are weighted more than studies with
poor precision. Precision of a study is often driven by the sample size of the study, so most
often, the greater the sample size the greater the study weight.81,82 However, precision is just
one of many factors that can influence the weight of a study.
A meta-analysis can be classified under two types of models: a fixed-effect model, or
a random-effects model. In a fixed-effect model, there is an assumption that there is just one
common (true) effect amongst all the included studies.82 This implies that all factors that
could influence the effect size will be the same and constant in all studies; the only difference
and variation from study to study only exists from sampling error. 77, 82 However, the fixedeffect model is often rarely used in practicality because the assumption of a true effect is
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implausible and there is often variance and heterogeneity in the studies. There can be many
differences in the studies in terms of study population, study demographics, and other factors
that vary. Thus, the random-effects model is most often used. In the random-effects model,
there is an assumption that the true effects are normally distributed, and the model tries to
deal with both the within study variance, and the between-study variance.81,82
To test and quantify heterogeneity, Cochran’s Q test, T2, and ! ! statistics are
computed.82 The Q score is a standardized measure which sums the squared deviation of each
individual effect size from the mean, multiplied by the weighted inverse-variance for a
particular individual study – this is also known as the weighted sum of squares. The use of
the Q score is to compare with the expected weighted sum of squares to test the null and get
an estimate of the excess variance.82,85 T2 (Tau-squared) measures the variance of the true
effects, and it is used to assign the study weights in the random-effects model. Tau is also
able to estimate the distribution of the true effects and evaluate the standard deviations.82,85
! ! represents the proportion of the observed variance with the real differences in the effect
size. ! ! is a descriptive statistic that essentially measures the inconsistency of study results
across all the studies.82,85 Higgins et al. (2003) gives recommendations on how to interpret
the ! ! . They suggest that a value of 25%, 50%, and 75% may be considered as low,
moderate, or high heterogeneity, respectively.82
Meta-analysis of diagnostic accuracy studies
In meta-analysis of diagnostic accuracy studies, the use of a hierarchical logistic
regression is a common analysis. There are several methods to statistically analyze diagnostic
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accuracy data which includes the use of the hierarchical summary receiver operating
characteristic (HSROC) model, and the bivariate model.83,84 In many updated statistical
packages that exist in statistical software, the statistical command often fits the model of both
the HSROC and bivariate parameterizations called a hierarchical logistical regression, for
example the “metandi” command in STATA.85 The advantage in using hierarchical logistic
regression for the meta-analysis of diagnostic studies is its ability to perform statistical
distributions at two levels. 83,84 The first level accounts for the within-study variability using
binomial distributions by assessing the number of true positive and true negative cases. The
second level accounts for between study variance using logistical (log-odds) transformation
of the sensitivity and specificity.83,84
In the instance of diagnostic accuracy studies, the effect size and the measurement
required for the meta-analysis are the number of true positives (tp), false positives (fp), false
negatives (fn), and true negatives (tn).86 These values are known as a confusion matrix, and it
is regularly used to calculate the sensitivity and specificity for diagnostic tests. True positive
refers to a positive diagnosis for a patient with the disease of interest, and a fp refers to a
positive diagnosis for a patient free from the disease of interest. While tn refers to a negative
diagnosis for a patient who is free of the disease of interest, and a fn refers to a negative
diagnosis for a patient with the disease of interest.86
The sensitivity refers to the proportion of individuals with a condition that received a
positive result on the test. In an example considering cataract diagnosis, sensitivity is the
proportion of confirmed cataract patients who received a cataract diagnosis. Whereas
specificity refers to the proportion of individuals who do not have the condition of interest
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that received a negative result on the diagnostic test; these are the non-cataractous patients
who received a no-cataract diagnosis from the screening procedure.86 The calculations for
sensitivity and specificity are shown in (1) and (2).
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Using the sensitivity and specificity values, a summary receiver operating
characteristic (SROC) plot can be constructed in which the sensitivity on the y-axis is plotted
against the specificity on the x-axis.85 Unlike a conventional receiver operating
characteristics plot, there are no lines that connect the plots with each other because each plot
is a different study rather than a different threshold within the same study. Each study in an
SROC plot is indicated by a circle and the size of the circle represents the sample size of each
study.85
The HSROC model is based on an underlying SROC plot, and it makes the same
normality assumptions as in a random-effects model.85 The parameters included in the
HSROC model include the mean and variance of the accuracy parameter, a positivity
parameter with a mean and variance, and a constant shape parameter. A plot of the fitted
HSROC model will continue a summary curve, a summary operating point for the pooled
sensitivity and specificity value, the 95% confidence region, and the 95% prediction region.85
The 95% confidence region is the area for the point estimate of the sensitivity and specificity,
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while the 95% prediction region is the confidence region for the forecasted sensitivity and
specificity of future studies.85
The bivariate model models the same parameters as the HSROC model, but it utilizes
the log-odds transforms for a bivariate normal distribution between the included studies.83,85
The output of these models will give the summary values and confidence intervals for
sensitivity and specificity, and this can be graphically modelled back in the linear scale.
Additionally, the diagnostic odds ratio (DOR), and positive and negative likelihood ratios
(LR +/-) can be retrieved from the computed sensitivity and specificity values.86
Economic Evaluations
Through an economics perspective, resources are always scarce, and choices must be
made towards the optimal allocation of resources.87 A healthcare economic evaluation is the
analysis of the cost and effectiveness of at least two treatments, and it is an important
decision-making consideration for healthcare officials and administrators. Economic
evaluations involve placing a value on a certain course of action, and it can motivate a
reallocation of resources.87,88 The goal of an economic evaluation is often to identify which
program, treatment or intervention is most efficient and it begins with a desired policy
objective.
In Canada, where there is publicly financed health insurance (ie. OHIP in Ontario),
economic evaluations are important for optimal resource allocation and to determine which
health programs or interventions are funded and covered by the government.89 Often, based
on the results of an evaluation, they determine which drugs and interventions are covered in
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the public health insurance plan and included in the schedule of benefits. 90 In low-to-middleincome countries (LMIC), knowing the most cost-effective intervention can inform on
programs and interventions that can be implemented at a lower cost, and potentially serve a
wider range of under-serviced populations.89
In health economic evaluations, the consequence is a more complicated measure to
obtain because different people have different views on how to assign social value towards a
health gain or health loss.87 The consequences of a health program can reflect a change in
health status of patient, change in health sector resources consumed, or change in non-health
effects (ie. changes in productive working time, time saved).87,88 The three types of economic
evaluations reflect these measures and preferences.92
Within the healthcare sector, often the final policy objective is to produce the most
health-related welfare by observing any changes to the health status of the patient – this may
be looking at quality of life or disability adjusted life year measures.87 However, there are
other intermediate outcomes that may reflect change in other important clinical indicators
pertinent to other parties such as physicians, or family and caregivers of the patient.
Therefore, the perspective (or viewpoint) that is used in an economic evaluation is important
because a certain treatment or program may look unattractive when other perspectives are
being considered.92 These perspectives can include the individual patient, a specific
organization, the Ministry of Health, or a societal perspective.
Another methodological consideration in an economic evaluation is the time horizon
of the study. Many studies will capture the entire lifetime of a patient in order to assess both
intended and unintended effects of a patient’s life as a result of health intervention.87,92 For
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example, if a study was assessing the mortality of a patient after a certain medical treatment,
a short time horizon may lead to an over optimistic view of the analysis. A longer time
horizon which follows through the patient’s life course would be more beneficial and fully
encompassing the patient’s experience.87 However, this is no standard time horizon in
economic evaluations because each study has its own goals and scope. For economic studies
that investigate benefits that occur in the shorter term such as the number of cases detected
by a screening program or reduction in the number of medical visits by a patient, then a
shorter time horizon may also be appropriate.87
Methods of Economic Evaluations
There are three main types of economic evaluations: cost-effectiveness analysis
(CEA), cost-utility analysis (CUA), and cost-benefit analysis (CBA). All analyses use similar
monetary unit measurement, but the consequences may be differently reported and used in
each type. Cost-minimization analysis is also another form of economic evaluation, although
this method is more outdated and less robust than the other method.
Cost-effectiveness analysis is a type of economic evaluation that assesses the cost per
unit effect achieved – it measures the consequences in natural units (ie. life-years gained,
cases averted, etc.).87,88 The purpose of a CEA can be to compare the costs of different
medical treatment, programs, or interventions aimed at the same health problem, and
evaluate the expected benefits, but a CEA does not place a social value to the consequence.88
For example, if there is an alternative dialysis program that may prolong the life of a patient
with renal failure, then the CEA would be interested in looking at the extra cost per life-year
gained as a result of the new treatment program.88 For cancer screening programs, the cost of
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a ‘detected case’, ‘case averted’, or ‘patient diagnosed’ by the screening intervention may be
the more relevant outcome of interest.87 However, there are limitations to a CEA because it
may be difficult to evaluate the opportunity costs and benefits forgone in other programs.
Taking the cancer screening program for example again, although a CEA may be able to
capture the number of cancers detected, the scope of the analysis does not account for the
type of cancer or the stage of cancer which can have very different health effects on the
individual patient.88
A decision tree can be generated to compare two separate interventions, and case-base
probabilities are inputted into the analysis. Through inputting the probabilities of an output
with the costs and effectiveness, a simple cost-effectiveness measure can be computed to
compare the interventions.87 An incremental cost-effectiveness ratio (ICER) describes the
average incremental cost associated with one additional unit of the measure of effect, and
there will be a dominated, dominant, or undominated intervention. An intervention is defined
as dominated when the intervention is more costly and produces lower effects or
consequence. The calculation of an ICER is expressed in (3) which describes the change in
incremental resources required by the intervention, divided by the change in incremental
health effects gained by the intervention.87,88

(3) !567 =

58)+ ('9 − 58)+ 8;<
611'3+ ('9 − 611'3+ 8;<

A CEA generates one of nine possible “dominance” outcomes when a new treatment
or program is being compared to another (Table 2.2).87,88 In instances where there is clearly
one program that is less costly and more effective, then this program is said to be
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absolutely/strongly dominant. There are also outcomes that may be classified as “weak
dominance” such that a program may be equally as effective as the comparator but costs
more or less, or a program that is more or less effective but costs the same as the
comparator.88 Finally, there are outcomes that are classified as “non-dominance” in which
there is a trade-off between programs to see if the added effects generated are worth the extra
costs, or if the lowered costs justify the lowered effects.88
The results of a CEA can also be shown on a cost-effectiveness plane which plots the
ICER onto a plane with four quadrants: northeast, southeast, southwest, and northwest.93 The
vertical axis represents the change in cost, and the horizontal axis represents the difference in
effect. A positive ICER slope represents a trade-off for either intervention; the northeast
quadrant represents that the new program is more effective and more costly than the
comparator, and the southwest quadrant represents the new program is less effective and less
costly than the comparator.87 A negative ICER slope needs to be interpreted with caution
because it represents two extremes: the new program is dominant (southeast quadrant), or the
new program is dominated (northwest quadrant).87,93
A second type of economic evaluation is a cost-utility analysis (CUA) which values
health outcomes and consequences in terms of a generic measure of health gain (ie. qualityadjusted life years (QALY), disability-adjusted life years (DALY), healthy years
equivalent).87,88 These estimates of health utility can quantify the quality of life and
productiveness of a patient using a rating or valuation from 0 to 1.88 Using these ratings, each
case that is considered in the CUA can be adjusted by the length of time affected by the
disease of interest. The benefits to utilizing the health utility of the patient is that a patient’s
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health status can be considered after the implementation of the new program or treatment.88
If a patient with severe vision loss as a result of cataracts receives a successful cataract
surgery and regains 20/20 vision, the QALY of the patient would inevitably increase postsurgery. If the patient does not receive cataract surgery or has an unsuccessful surgery, then
their vision will continue to deteriorate and their QALY may continue to decrease over the
time horizon of the study.94
The third type of economic evaluation is a cost-benefit analysis (CBA) which is
similar to a CUA, but the consequence is valued in money or willingness-to-pay (WTP).87,88
The result of a CBA is often stated as a form of ratio of costs to benefits, or a sum of net
benefits or loss of one program compared to the other. A CBA can indicate whether a
program is worthwhile at all to be implemented. In a CBA, individuals express their
hypothetical WTP which is a scenario where the individual can consider their willingness-topay in a dollar amount to mitigate a certain health risk.88 Based on the pre-determined WTP,
the WTP can be plotted on a cost-effectiveness plane to determine if the new program or
treatment should be accepted. For example, if the WTP is $40,000/QALY, then this is the
cost-effectiveness threshold that would be used to draw an acceptability curve to illustrate if
one intervention is favoured over the other. It is noted that CBA is used more for feasibility
studies rather than full program implementation purposes.88

2.1.8 Conclusion
In conclusion, cataract is a global disease that requires attention and research.
Cataracts is the leading cause of blindness in adults, and the aging population of Canada and
the world will inevitably cause a massive increase in cataract cases.3 The diagnosis and
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treatment of cataracts warrants research, and the use of AI and ML can assist clinicians in the
care of cataracts. There is potential for AI screening programs for diagnosing eye diseases
such as cataracts, as shown by the ARDS program by Google Health. Currently, there are
many research teams who are investigating the use of ML classifiers for cataract diagnosis,
and there is great potential for its regular clinical use. However, there remains a gap in the
literature for a meta-analysis on the diagnostic accuracy of machine learning classifiers for
cataracts, and a cost-effectiveness analysis for AI screening programs for cataracts in rural
regions.

2.2 Thesis Rationale
The utilization and implementation of artificial intelligence and machine learning in
the healthcare setting has been on the rise in the past few decades. Complex algorithms and
software have been developed to resolve complex problems and processes within medical
data and clinical decisions.59,63 The incorporation of these new and modern technologies has
the ability to improve medical care delivery, and the patient experience in our healthcare
system. The use of AI for telemedicine has shown benefits for patients in terms of access to
care and healthcare equity. There continues to be large amounts of studies on AI and ML
within the healthcare field published every year due to the increasing trend of digital
medicine.61
Additionally, currently in Nepal, there is approximately an 8.5% prevalence of any
type of cataract among adults.36 Thus, many individuals are impacted by cataracts, and it is a
very relevant aging health condition seen across many adults. The field of ophthalmology
seems to be a very attractive field for AI development perhaps due to the readily available
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datasets of ocular images. Large technology companies such as Google and IBM have
invested in large research teams to make developments in these areas.59 Therefore, this thesis
is important because it addresses key topics within artificial intelligence, ophthalmology, and
global health that remains unanswered in the current body of literature.
Many studies have claimed that the use of machine learning can provide an accurate
and cost-effective alternative to regular clinical practice of treatments or interventions in the
healthcare setting. However, there have not been any studies that prove this to be true for
cataract diagnosis.91 It is hypothesized that ML screening programs will in fact be superior to
human assessments in both the diagnostic accuracy and direct costs.
This thesis will investigate, at a high level, the general diagnostic accuracy of all
machine learning classifiers for cataracts that are currently in literature in both published and
unpublished sources. To date, there are no systematic reviews or meta-analysis on the use of
machine learning for cataract screening.91 By investigating and exploring the sensitivity and
specificity of these novel algorithms, it can give more information to researchers and
clinicians on whether more development of algorithms is warranted to produce better
diagnostic accuracy, or if current algorithms are capable to be implemented to the regular
clinical setting in hospitals and ophthalmology clinics.
Equally as important to the ML diagnostic effectiveness is the financial and health
economical consideration to this screening program. Health economic evaluations are also
warranted to demonstrate the financial feasibility of these new interventions and to assess the
long-term benefits of any investments. With human assessment of cataract diagnosis, it can
involve costly personnel (ophthalmologists, eye specialists) in every step of the patient care.
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There is currently a paucity of literature on the CEA of any AI-related interventions. In fact,
in a systematic review by Wolff et al., the authors found only 6 studies that met their
objective of summarizing cost-effectiveness studies dedicated to AI in healthcare.91 Out of
the 6 studies, no studies were identified to have comprised of a methodologically complete
cost impact analysis. To the best of our knowledge, the cost-effectiveness analysis in Chapter
04 presents as one of the first cost-effectiveness analysis of a machine learning screening
program for cataracts.
In Nepal, there is currently no machine learning screening program readily available
for diagnosing cataracts. Given the potential of machine learning diagnosis utilized for other
diseases such as diabetic retinopathy, cataract diagnosis can benefit from the same
developments and provide timely patient referrals. The thesis rationale is that a ML-based
screening program for cataracts may be a feasible and viable alternative over the traditional
diagnostic eye camps for cataracts by assessing the diagnostic accuracy and costeffectiveness.

2.3 Thesis Objectives
This thesis aims to evaluate the effectiveness of ML classifiers for the diagnosis of
cataracts through two objectives: 1) assessing the diagnostic accuracy, and 2) determining the
cost-effectiveness.
Objective 1 – Diagnostic accuracy
To systematically review and meta-analyze the diagnostic accuracy of ML classifiers
for cataracts among all adult and pediatric eyes available in datasets to assess their accuracy
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and reliability to be implemented in real clinical settings. Chapter 03 will aim to qualitatively
and quantitatively summarize the existing body of knowledge pertaining to the accuracy of
novel ML classifiers developed and compute a pooled-sensitivity and specificity estimate.
Objective 2 – Cost-effectiveness
To determine the cost-effectiveness of implementing a fully automated ML-based
screening program in eye camps compared to the current standard eye camps for the
diagnosis of cataracts for the adult population in rural Nepal.
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2.5 Table
Table 2.1 Ophthalmic evaluation for the diagnosis and treatment of cataract. (Table adapted
from the Canadian Ophthalmological Society)34
Evaluation
Patient History

Measurements

Examinations

Details
-

Patient’s assessment of functional status

-

Pertinent medical conditions

-

Current medications

-

Allergies to medications and latex

-

Risk factors that could affect the surgical plan

-

Previous ophthalmic surgery, including refractive surgery

-

Visual acuity with current correction at distance and at near

-

Best-corrected visual acuity, including under glare conditions

-

Intraocular pressure

-

External (lids, lashes, lacrimal apparatus, orbit)

-

Ocular alignment and motility

-

Slit-lamp biomicroscope of the anterior segment

-

Dilated examination of the lens, macula, peripheral retina, optic nerve,
and vitreous; B-scan ultrasound of fundus if inadequate view clinically

-

Assessment of relevant aspects of the patient’s mental and physical status
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Table 2.2 Possible results from a cost-effectiveness analysis – dominance chart
Incremental effectiveness of new program
compared to control

Incremental
cost of new
program
compared to
control

More

Same

Less

More

Non-dominance
(trade-off)

Weak
dominance
(reject new
program)

Strong
Dominance
(reject new
program)

Same

Weak
dominance
(accept new
program)

Non-dominance
(neutral)

Weak
dominance
(reject new
program)

Less

Strong
Dominance
(accept new
program)

Weak
dominance
(accept new
program)

Non-dominance
(trade-off)
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56

3

Diagnostic Accuracy of Machine Learning Classifiers for
Cataracts: A Systematic Review and Meta-analysis

3.1 Introduction
3.1.1 Background
A cataract is the opacification of the lens in the human eye which results in
cloudiness and poor visual acuity.1,2 The development of cataracts is often related to age,
trauma, and even congenital factors.2-5 According to a WHO report, more than 50% of the
world’s first cause of blindness is due to cataracts and it continues to be the leading cause of
blindness, especially in low to middle-income countries.6 While cataract is commonly found
in adult and elderly patients, pediatric cataract has an estimated prevalence of 4.24 per
10,000 live births, and it is the major causes of childhood blindness.4 On a global level,
cataract has contributed to 17.7 million disability-adjusted life years, a measure that
represents the total number lost to disability or premature death, and it is continuing to be
increasing.7
In current clinical practice, ophthalmologists commonly use several diagnostic tests
for cataracts. Slit-lamp imaging is the most common imaging technology that utilizes an
intense line of light to illuminate the eye and to look for abnormalities. Clinicians often use
the Lens Opacities Classification System III for grading images of cataract.1,2
The early diagnosis of patients with cataracts can often lead to improved visual
outcomes because patients can quickly receive treatment and cataract surgery.8,9,10 However,
this process is often stalled or delayed when people in remote and under-serviced areas such
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as First Nations communities, rural regions, or low-to-middle income countries do not have
access to ophthalmologists, treatment, or healthcare resources.11,12 Often, ophthalmologists or
other trained eye specialists in urban settings will travel to these under-served areas to
perform diagnosis, check-ups, and treatments.12 Considering the aging population, the
increased number of cataract cases can potentially contribute to the demand of
ophthalmologists to rise. Ophthalmologists are facing high prevalence of occupational
burnout and they have high demands of patient care and overtime work.13,14 There is an
evident need for the use of AI as it holds great potential for its application in clinical
settings.11,12
AI has been an emerging technology in the medical field, and it can be an influential
modern technological innovation. The role of AI is to mimic and simulate a human’s mental
process through computers to perform complex and sophisticated tasks. Machine learning is
an application of AI, and its purpose is to automatically perform tasks through training and
learning processes.15 Researchers have used ML to train computer algorithms to
automatically detect eye diseases such as AMD, glaucoma, and diabetic retinopathy through
processing large sets of fundus, optical coherence tomography, and slit-lamp images.16-21
Machine learning classifiers such as support vector machines, convolutional neural networks
and random forests have been used to obtain a cost-effective, simple, and fast diagnosis of
eye diseases.

3.1.2 Objective
The applications of AI in the field of ophthalmology are growing rapidly and it is
proven to be a powerful tool for the diagnosis of eye diseases. There have been numerous
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systematic reviews published on the diagnostic accuracy of AI for glaucoma and diabetic
retinopathy.22,23 It is to the best of our knowledge that this is the first systematic review of its
kind. The objective of this study is to systematically review and meta-analyze the diagnostic
accuracy of machine learning classifiers for cataracts among all pediatric and adult eyes
available in databases to assess their accuracy and reliability to be implemented in real
clinical settings.

3.2 Methods
This systematic review has been registered in PROSPERO (CRD42020219316) and it
follows PRISMA guidelines (Appendix A).24

3.2.1 Search Strategy
An initial scoping search was performed using PubMed, Google Scholar, and Web of
Science. A systematic and comprehensive database search included MEDLINE/PubMed,
EMBASE, CINAHL and ProQuest Dissertations and Theses to find articles on current
artificial intelligence technologies used in the field of ophthalmology for the diagnosis of
cataracts. The search was carried out using keywords and controlled terms for the following
concepts: “Artificial intelligence” AND “Diagnosis” AND “Cataracts”. The search strategy
and keywords for each database is detailed in Appendix B and the searches were conducted
until September 12, 2021. The search was limited to English and human studies only. No
limits were placed on publication date and study location to maximize our eligible studies.
OVID AutoAlerts for MEDLINE and EMBASE databases were used to send weekly updates
for any new published literature that the search strategy encompassed.
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In addition, grey literature searches were conducted in order to obtain a
comprehensive search. Conferences held through the American Academy of Ophthalmology,
the Association for Research in Vision and Ophthalmology, and the Canadian Society of
Ophthalmology were searched in all available years. We searched through the conferences
until September 12, 2021. Keywords that were used for the grey literature search consisted of
“artificial intelligence” and “diagnosis”. The search strategy and search results for each
conference is displayed in Appendix C. Forward and backward citation tracing were carried
out on studies that were included after the full-text screening. Refer to the Preferred
Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) flow diagram for
more details.24

3.2.2 Inclusion and Exclusion Criteria
This systematic review included all studies that utilized artificial intelligence to
diagnose cataracts on human eyes — there was no restriction in the age of the eyes. Any ML
classifiers such as neural networks, Random Forests, adaptive boosting, or support vector
machines that were able to differentiate between healthy and cataract eyes were included.
The ML classifier must include a learning, training or validation processes when evaluating
the images. If the study mentioned a computer assisted or automated process without the
mention of AI or a learning process, then the study was excluded. We included studies that
used AI algorithms to make a first diagnosis of cataracts from healthy eyes, or the AI was
able to differentiate between cataract eyes and healthy eyes. Studies that investigated the use
of AI for grading cataracts were excluded.
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Additionally, all imaging techniques were included in this review; this included
fundus imaging, slit lamp imaging, or visible wavelength images. Studies that reported
diagnostic performance indicators such as sensitivity and specificity were also included. The
studies must also include a reference standard, confirmed, and validated by trained clinicians
or ophthalmologists. Included publications must be primary studies, and there were no
restrictions on study design; ophthalmology news articles, opinion pieces, and case reports
were excluded. Only studies in English were included, and there was no restriction placed on
study location or publication date.

3.2.3 Screening
Database search results were all imported into Covidence systematic review software
(Veritas Health Innovation, Melbourne, Australia). All duplicated articles were removed in
Covidence and two levels of systematic screening were conducted by two independent
reviewers (RC & SS). When consensus could not be reached between the two reviewers, all
disagreements were resolved by discussion of the two reviewers. The first level of screening
consisted of a broad title and abstract screening. If the study title and/or abstract mentioned
the use of AI and the diagnosis of cataracts, the study was included and moved on to the
second screening; the rest of the articles were excluded. The second level of screening was a
full-text screening, and we examined each article to choose relevant studies that matched our
research question. The article must consist of a first diagnosis of cataracts using an AI
algorithm. However, the technology must be an advanced ML classifier that includes a
training and processing element for the diagnosis of cataracts. The included studies moved on
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to the risk of bias assessment. If data from the same study was discovered to be reported in
multiple papers, only the report with higher quality was retained.
Cohen’s kappa (κ) statistics were calculated at both screening levels before conflicts
were resolved as shown in Appendix D. We reported kappa values based on the
recommendations of Landis and Koch: greater than 0.75 represents excellent agreement
beyond chance, below 0.40 represents poor agreement, and 0.40 to 0.75 represents
intermediate to good agreement.

3.2.4 Risk of Bias Assessment and Data Extraction
To assess the risk of bias of the included articles, the Quality Assessment of
Diagnostic Accuracy Studies (QUADAS-2) tool was used to assess the level of bias and
concerns of applicability.25 Two independent reviewers (RC & SS) conducted the risk of bias
and any disagreements were resolved by discussion. QUADAS-2 considered 4 domains:
patient selection, index tests, reference standard, and flow and timing. Each of the domain
was given a risk of bias score to assess whether there was high, low, or unclear bias. The
QUADAS-2 tool was not intended to provide a summary quality score. All studies were
included for this systematic review.
A data extraction form was created to collect relevant data and details of each of the
included studies. A pilot extraction form was first created for a subset of included studies in
order to determine what information was most relevant and pertinent to this study. Study data
were extracted by one reviewer (RC). The following data were extracted from each study:
author, year of publication, study location, study design, ML classifier, type of imaging,
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number of study participants, number of images used, training and testing process, database
and datasets used, diagnosis reference standard, area under curve, sensitivity, specificity, and
accuracy. Additionally, other outcomes that were extracted if reported in the studies were the
tn, tp, fn, fp, and total number of images classified as healthy or cataractous. Data extraction
table for the meta-analysis is outlined in Appendix E.

3.2.5 Statistical Analysis
Data was synthesized and analyzed using STATA 15.0 (STATA Corp, College
Station, Texas, U.S.A.) for the diagnostic accuracy of machine learning for cataracts. The
extracted data of interest were the sensitivity, specificity, and area under curve values of the
ML classifiers used. A hierarchical bivariate random effects model was conducted.
Hierarchical logistic regression was used to determine the pooled estimates of sensitivity and
specificity of diagnostic accuracy. The summaries of the fitted Hierarchical Summary
Receiver Operator Characteristic (HSROC) model, the summary receiver operating
characteristics (SROC) curve, the 95% confidence interval and the 95% prediction region
were plotted graphically. Sub-group analysis was conducted based on adult and pediatric
cataracts.
The positive/negative likelihood ratios (LR+/LR-) were calculated using bivariate
models to generate estimates of the likelihood of a positive/negative test. From this result the
diagnostic odds ratio (DOR) was calculated to determine the relative diagnostic
effectiveness. DOR is the ratio of the odds of a positive screen test in a cataract case relative
to the odds of a negative screen test in a non-cataract case.
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Forest plots showing the within-study estimates and confidence intervals for
sensitivity and specificity were plotted separately. For each study, the sensitivity and
specificity were aggregated using the fixed or random-effects model based on the absence or
presence of heterogeneity to estimate the summary effect. To test for heterogeneity, ! !
statistics, Q-value, and = ! statistics were computed. An ! ! value of less than 50% implies
low heterogeneity, and in these cases, a fixed-effect model was computed. An ! ! statistics of
50% or more represents high heterogeneity, and in these cases a random-effects model was
calculated. Additionally, a high Z-value, a low p-value (< 0.01) and a large = ! value implies
significant heterogeneity and therefore, a random-effects model was computed.

3.3 Results
3.3.1 Search Results and Study Characteristics
The inclusion and exclusion process are shown by Figure 3.1 using the PRISMA
flow diagram. In total, the search strategy yielded 150 articles, and the grey literature search
yielded 35 articles. However, 50 of those articles were identified as duplicates, resulting in
135 articles entering the first level title and abstract screening. In the first level, 107 articles
were excluded, and 28 studies moved onto the final level (full text) screening. After the full
text screening, seven studies were excluded due to wrong study outcomes and comparators,
and 21 studies met the inclusion criteria. The kappa statistics score was 0.72 and 0.84 at each
stage of screening — this was considered to be moderate to high agreement from both
reviewers. The studies that were included after the last screening went through a risk of bias
assessment using the QUADAS-2 Tool. All 21 studies were included for the qualitative
synthesis26–46 and 11 of those studies were included for the meta-analysis.26,27,34–36,38–42,45
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The study characteristics of the 21 included studies are displayed in Table 3.1. All
included studies were conducted in Asian countries including China 27–29,33–36,38,40–45,
Singapore30–32, India26,37,39, and Japan46. Nine of the studies used slit-lamp images26,30–32,34–
36,40,45

, 11 studies used fundus images 27–29,33,38,39,41–44,46, and one used visible wavelength eye

images39 for the testing and training process. Among all the studies, there was a varied use of
different ML classifiers. The most common classifier used was support vector machines
(SVM) which was used by six studies28,31,32,38,39,41, and convolutional neural networks which
was also used by eight studies33,36,38,40,42,44–46. Other ML classifiers included backpropagation
neural network26,27, discriminant analysis29, AdaBoost (adaptive boosting)35,43, CC-Cruiser34,
and a novel ranking classifier.30 Each study had a unique training and testing process to teach
their classifier to differentiate between the healthy and non-healthy images.
In the included studies, there were multiple studies that overlapped in the use of
certain datasets including the Singapore Malay Eye Study, Childhood Cataract Program of
Chinese Ministry of Health, and the dataset from Beijing Tongren Eye Center of Beijing
Tongren Hospital. However, all studies differed in their choice of ML classifier, and number
of images used for training and testing. In studies Li et al. (2009) and Li et al. (2010), both
uses the same ML classifier, imaging technique, and dataset to detect cataract. Lin et al.
(2019), Lin et al. (2020), and Liu et al. (2017) investigated specifically on pediatric cataracts
and used the same available database from the Childhood Cataract Program in China. Among
pediatric cataracts, three studies contributed to four sensitivity and specific pairs in total.
Whereas among the adult cataracts analysis, there were nine pairs of sensitivity and
specificity pairs in total used for the quantitative analysis. All images that were used had
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been confirmed by a human grader such as an ophthalmologist, clinician, or clinical grader to
confirm the diagnosis of the eye.

3.3.2 Risk of Bias Assessment
Most of the studies that passed the full-text review had a low risk of bias in the four
domains; it was low risk in patient selection (76.2%), index tests (95.2%), reference standard
(95.2%), and flow and timing (76.2%). There was low concern of applicability in the patient
selection (85.7%), index test (95.2%), and reference standard (95.2%). The study by Shimizu
et al. was rated high risk across all domains because only its abstract was available. The risk
of bias assessment and concerns about applicability for each study are summarized in
Appendix F.

3.3.3 Diagnostic Accuracy of Machine Learning Classifiers for Cataracts in
Adults
Eight studies were used for the meta-analysis to conduct the analysis of diagnostic
accuracy for cataracts in adult patients. The SROC curve is represented in Appendix G
which plots the sensitivity against the specificity of each study. The SROC curve shows that
most of the included studies are scattered across the top right corner of the plot, and it
demonstrates that there is a high specificity and sensitivity of various ML classifiers.
Figure 3.2 shows the HSROC plot which illustrates the study estimates indicated by
the circles, the HSROC curve or summary curve, a summary operating point or the summary
value for sensitivity and specificity, the 95% confidence region (inner ellipse), and the 95%
prediction region (outer ellipse) for the summary operating point. The HSROC curve appears

66

in the left upper quadrant and has a large area under the curve. This is an indication that ML
classifiers are a relatively accurate method for diagnosis because the area under the HSROC
curve is large. Four studies fall outside the 95% confidence interval of the summary estimate.
The 95% prediction region is the estimate of future observations. The prediction region
shows a wide prediction region for the true predictions of both specificity and sensitivity;
there is a greater expected variability for the sensitivity.
The summary estimate for sensitivity was 0.948 [95% CI: 0.815-0.987] and
specificity was 0.960 [95% CI: 0.924-0.980] for cataracts screening using an ML classifier
(Figure 3.3). The summary estimates indicate that ML classifier correctly detects 94.8% of
cataract cases and correctly classifies 96.0% of those without cataract as cataract-negative.
The distribution of the studies in the plot demonstrates the variability of both specificity and
sensitivity amongst studies.
The positive likelihood ratio was 23.837 [95% CI: 12.241-46.419], while the negative
likelihood ratio was 0.054 [95% CI: 0.014-0.208] (Appendix H). This shows that the
likelihood of a positive diagnosis in a cataract case is greater than the likelihood of negative
diagnosis in a non-cataract case. The positive likelihood ratio is greater than one and it
represents that the positive diagnosis is associated with cataract. Because the negative
likelihood ratio is less than one, the ML classifier which gave a negative diagnosis is
associated with the absence of cataract. The effectiveness of the diagnostic accuracy of the
ML classifiers for cataract given by the diagnostic odds ratio is 442.248 [95% CI: 89.2012192.611] (Appendix H). This demonstrates that the relative odds of a positive screen test in
cataract cases are 442.248 times more likely than a negative screen test in a non-cataract
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case. Thus, the ML classifiers discriminate between the true negative and true positive
cataract images correctly and accurately.

3.3.4 Diagnostic Accuracy of Machine Learning Classifiers for Pediatric
Cataracts
A sub-group analysis was conducted for pediatric cataracts and a total of three studies
were used for the quantitative analysis for assessing the diagnostic accuracy of ML classifiers
for pediatric cataracts. Figure 3.4 shows the HSROC plot for pediatric cataracts. All four
classifiers fall within the 95% confidence interval (inner ellipse) of the summary estimate.
The 95% prediction region shows wide variability for the true predictions of both specificity
and sensitivity.
The summary estimate for sensitivity was 0.882 [95% CI: 0.696-0.961] and
specificity was 0.891 [95% CI: 0.807-0.942] for cataracts screening using an ML classifier
(Figure 3.5). The distribution of the studies in the plot demonstrates the variability of both
specificity and sensitivity amongst studies. The positive likelihood ratio was 8.119 [95% CI:
4.068-16.206], while the negative likelihood ratio was 0.133 [95% CI: 0.045-0.392] for
cataracts in children (Appendix H). The effectiveness of the diagnostic accuracy of the ML
classifiers for cataract given by the DOR is 61.200 [95% CI: 11.656-321.328] (Appendix H).
The relative odds of a positive screen test in pediatric cataract cases are 61.2 times more
likely than a negative screen test in a non-cataract case. Thus, the ML classifiers discriminate
between the true negative and true positive images correctly and accurately in child eyes.
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3.4 Discussion and Conclusion
This systematic review and meta-analysis included 21 full text articles for the
qualitative synthesis and 11 full text articles for the quantitative synthesis. In the systematic
review, 100,134 images were used for training and validation of the ML classifiers for
diagnosing cataracts in human eyes. For the adult cataract meta-analysis, 74,188 images were
used included for the analysis, and 5246 images were used for the pediatric cataract subgroup
analysis. To the best of our knowledge, this is the first review of its kind to assess the
diagnostic accuracy of ML classifiers for cataracts. ML classifiers are advantageous at
detecting true positive cases of cataracts and they have very high DOR estimates.
Given the COVID-19 pandemic, the role of telemedicine — more specifically in
teleophthalmology — has demonstrated a growing importance in healthcare, and the use of
AI algorithms can further assist clinicians in making clinical decisions. The use of ML has
demonstrated good use for offering cataract diagnosis services to people in under-developed
and remote regions.11,12 This alternative method of receiving healthcare benefits both the
patients and the healthcare system because there is reduced wait and travel times, increased
specialist referral rates, and reduced patient costs. In urban settings, the use of ML for
diagnosis can reduce patient load, wait times, and improve efficiency of ophthalmology
clinics.12
The results of the pooled sensitivity and specificity estimates for diagnosing cataracts
have shown that ML-classifiers perform with high accuracy for both true positive (tp) and
true negative (tn) cases. It is also equally important to consider the number of cases that are
classified as false negative (fn) and false positive (fp) in order to assess how many patients
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may be underdiagnosed and in need of cataract treatment. A missed cataract diagnosis may
significantly affect the patient’s quality of life and quality of vision, and it may result in a
delayed cataract treatment and follow-up.8,9 When assessing the accuracy of the ML
classifiers, both the sensitivity and specificity of the diagnostic technology must be fully
considered.47 All included qualitative publications in this study reported an accuracy
proportion in their article, however, single accuracy proportions do not indicate whether there
is a trade-off between the sensitivity or specificity of the test. For future diagnostic accuracy
studies, it is encouraged for all authors to report the sensitivity, specificity, tn, tp, fn, and fp
values for researchers and clinicians to make better informed decisions.
Additionally, meta-analysis of observational studies is influenced by inherent
biases.48 Factors such as the hospital and study location, race and age of study participants,
and type of imaging technique can influence the study results. The clinical diagnosis and
confirmation of cataracts may also be subject to each ophthalmologist or retinal specialist
and study location. All included studies had a reference standard which may be an
ophthalmologist, an eye specialist, or a professional/clinical grader. However, not all studies
explicitly stated the clinical guidelines or cataract classification systems that the reference
standard used to provide a cataract diagnosis. An ophthalmologist’s number of years of
experience in the field, and an ophthalmologist’s field of expertise in ophthalmology are
additional factors that may influence the study results.
In training a machine learning algorithm in ophthalmology, there can be multiple
imaging modalities that researchers may use including slit-lamp imaging, fundus imaging or
OCT imaging. For cataracts, it is common to use slit-lamp or fundus imaging as shown in
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Table 3.1. Due to the differing image modalities used by different studies, there may be
potential bias in the results because each individual algorithm learns to read and process the
image types differently — this may increase the between study heterogeneity. Despite the
variation in ML classifiers within the slit lamp imaging and fundus cohorts, all the included
studies for the quantitative analyses displayed consistent results. Based on this study’s
inclusion and exclusion criteria, only two studies that used slit-lamp images would have been
included for a potential subgroup analysis. Therefore, a subgroup analysis was not conducted
due to the small sample size and insufficient power in the analysis.
All included studies originated from three study countries: China, Singapore, and
India. Due to the limited eye database and datasets available in these countries, there were
database overlaps throughout the included studies. Datasets from Beijing Tongren Hospital
and the Childhood Cataract Program of Chinese Ministry of Health (CCPCMOH) from
China were most used. CCPCMOH was the only database used for the pediatric cataract
subgroup, thus more images of pediatric eyes with cataract are needed for continued research
in the future. The pediatric cataract results from this study should be interpreted with caution
due to the limited number of studies available. This suggests that more expansive research is
warranted in other regions and countries to retrieve more unique eyes for this analysis.
In conclusion, the diagnostic accuracy of ML classifiers for adult and pediatric
cataracts is very high and the diagnostic test performance shows very promising results. The
prospects of using ML for the diagnosis of cataracts in real clinical settings is a possibility,
although the extent of our findings and the timeline of this implementation still needs to be
established. This study demonstrates only one facet of the application of artificial intelligence
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in the healthcare field and ophthalmology. There are endless opportunities for the
implementation of AI in medical care as novel research and new algorithms are developed.
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Table 3.1 Study characteristics of the included studies

Study

Acharya et
al. (2009)

Cao et al.
(2020)

Dong et al.
(2017)

Guo et al.
(2015)

Huang et
al. (2009)

Li et al.
(2009)

Study
Location

India

China

China

China

Singapore

Singapore

Patient
Type

ML Classifier

Adult

Backpropagation
Neural Network

Adult

Backpropagation
Neural Network

Adult

Adult

Adult

Adult

SVM

Imaging
Technique
and Model

Slit Lamp

Fundus

Fundus

Discriminant
analysis

Fundus

Novel Ranking
Classifier

Topcon
DC-1
Digital Slit
Lamp

SVM

Topcon
DC-1
Digital Slit
Lamp

# Study
Participants

140

NR

NR

NR

1000

3280

#
Images

Training and
Testing Process

Database and Datasets

Reference
Standard

2520

1620 images used for
training, 900 images
used for testing

Department of
Ophthalmology, Kasturba
Medical College Hospital,
Manipal, India

Ophthalmologist

1355

452 images used for
training, 903 images
used for testing

Beijing Tongren Eye
Center of Beijing Tongren
Hospital

Two
ophthalmologists

7851

5495 images used for
training, 2356 images
used for testing;
repeated training and
testing 50 times

Department of
Ophthalmology, Tsinghua
University

Professional
doctors

445

312 images used for
training, 133 images
used for testing;
repeating the
procedure 100 times

Community clinics, remote
rural hospitals and other
hospitals, sharing the
healthcare resources
through the internet

Ophthalmic
experts or
ophthalmologists

Singapore Malay Eye
Study (SiMES)

Ophthalmologists
using Wisconsin
cataract grading
system

Singapore Malay Eye
Study (SiMES)

Human graders
using the
Wisconsin
cataract grading
system

1000

5820

5-fold cross validation

100 images used for
training, 5490 images
used for testing
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Li et al.
(2010)

Li et al.
(2018)

Lin et al.
(2019)

Lin et al.
(2020)

Liu et al.
(2017)

Pratap &
Kokil
(2019)

Singapore

China

China

China

China

India

Adult

SVM

Adult

CNN ResNet50

Pediatric

Pediatric

Pediatric

Adult

CC-Cruiser

Random Forest,
AdaBoost

CNN

SVM

Topcon
DC-1
Digital Slit
Lamp

Fundus

Slit Lamp

Slit Lamp
BX900

Slit Lamp
BX900

Fundus

3280

248

350

2005

NR

NR

5850

100 images used for
training, 5550 images
used for testing

Singapore Malay Eye
Study (SiMES)

Human graders
using the
Wisconsin
cataract grading
system

8030

7030 images used for
training, 1000 images
used for testing

Beijing Tongren Eye
Center of Beijing Tongren
Hospital

Professional
graders

350

CC-Cruiser is an
ophthalmic AI
platform developed by
Zhongshan
Ophthalmic Centre
(ZOC)

Childhood Cataract
Program of Chinese
Ministry of Health
(CCPMOH)

Senior
Consultants

4-fold cross validation

Childhood Cataract
Program of Chinese
Ministry of Health
(CCPMOH)

Two
ophthalmologists

4-fold cross
validation; each test
was performed with
50 iterations

Childhood Cataract
Program of Chinese
Ministry of Health
(CCPMOH), Zhongshan
Ophthalmic Centre Sun
Yatsen University

Two
ophthalmologists

400 images used for
training, 400 images
used for testing

High resolution fundus
(HRF) image database,
structured analysis of the
retina (STARE), standard
diabetic retinopathy
database (DIARETDB0), eophtha: a color fundus
image database, methods to
evaluate segmentation and
indexing techniques in the
field of retinal
ophthalmology

Ophthalmologic
Experts

2005

886

800
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(MESSIDOR) database,
digital retinal images for
vessel extraction (DRIVE)
database, fundus image
registration (FIRE) dataset,
digital retinal images for
optic nerve segmentation
database (DRIONS-DB),
Indian diabetic retinopathy
image dataset (IDRiD),
available datasets from Dr.
Hossein Rabbani, and other
internet resources

Ran et al.
(2018)

China

Adult

CNN - Random
Forest

Fundus

SV&R
(2018)

India

Adult

SVM

Visible
Wavelength
Eye Image

Shimizu et
al. (2021)

Japan

Adult

CNN

Slit Lamp

CNN - ResNet

Slit Lamp
BX900,
BQ900,
OVSII,
PSLClassic

Wu et al.
(2019)

Xu et al.
(2021)

Yang et al.
(2016)

China

China

China

Adult

Adult

CNN

Adult

SVM,
Backpropagation
Neural Network

Fundus

Fundus

NR

5-fold cross validation

NR

Two
ophthalmologists
and three
experienced
graders

129 images used for
training, 99 images
used for testing

Indira Gandhi Medical
College and Research
Institute, Puducherry

Ophthalmologist

NR

NR

Ophthalmologists

30132 images for
training, 7506 images
for testing

Chinese cataract screening
programme by the Chinese
Medical Alliance for
Artificial Intelligence
(CMAAI)

Three
ophthalmologists

8030

5621 images or
training, 2409 for
testing

Beijing Tongren Eye
Center of Beijing Tongren
Hospital

Ophthalmologist

1239

Images divided into 3
subsets. In each fold,
one subset chosen as
the testing set, the

Picture Archiving and
Communication System
(PACS)

Ophthalmologists

5408

64

228

NR

18,596

16,611

NR

NR

37,638

82
other 2 used for
training.

Zhang et al.
(2017)

Zheng et al.
(2014)

Zhou et al.
(2020)

China

China

China

Adult

Adult

Adult

CNN

AdaBoost

DST-ResNet

Fundus

Fundus

Fundus

NR

NR

1000

Cross validation

Beijing Tongren Eye
Center of Beijing Tongren
Hospital

Professional
graders

460

10-fold cross
validation; images
divided into 10
subsets. In each fold,
one subset is testing
set and another nine
subsets as training set

NR

Professional
ophthalmologists

1355

Images divided into 4
subsets. In each fold,
one subset is testing
set and another 3
subsets used as
training set

Beijing Tongren Eye
Center of Beijing Tongren
Hospital

Clinical graders

5620

AdaBoost, Adaptive Boosting; CNN, convolutional neural network; DLS, deep learning system; SVM, support vector machine; LCP, Linear Configuration Patterns; NR, not reported
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Figure 3.1 PRISMA flow diagram showing the study selection process and reasons for
exclusion
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Figure 3.2 Hierarchical summary receiver operating characteristic plot for cataracts in adults
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Figure 3.3 Forest plot of the pooled sensitivity and specificity estimates for the ML
classifiers for cataracts in adults
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Figure 3.4 Hierarchical summary receiver operating characteristic plot for pediatric cataracts

Figure 3.5 Forest plot of the pooled sensitivity and specificity estimates for ML classifiers
for pediatric cataracts
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CHAPTER 4

88

4

The Implementation of a Machine Learning-Based Cataract
Screening Program in Rural Nepal: A Cost-Effectiveness
Analysis

4.1 Introduction
Cataract is the opacification of the human lens in the eye, and it causes cloudiness and
blurriness in the patient’s vision.1–3 Cataract is the leading cause of blindness and vision loss
in many low-to-middle income countries (LMIC) due to many barriers to accessing eye care
services.4–6 In Southeast Asia alone, the global health burden of cataract vision loss was
approximately 125 disability-adjusted life years (DALYs) per 100,000 people — the highest
crude DALY rate out of all WHO regions.7,8 In Nepal, the infrastructure to support eye care
services and examinations have been growing in the past few decades, and there have been
many improvements to provide Nepalis with an accurate cataract diagnosis.9–11
In 2015, Nepal promulgated a new constitution which replaced their original unitary
government with a federal system of government consisted of three levels: federal,
provincial, and local governments.12,13 In revamping the constitution, the Ministry of Health
and Population in Nepal was also restructured to follow the new federal structure in hopes of
improving the federal health infrastructure. However, the crux of federalization and the
challenge in Nepal’s healthcare system is the means of financing health care.14 Based on
statistics by the WHO in 2019, the annual health spending per capita in Nepal was $53
USD.15 Nearly 60% of the total health expenditure came from out-of-pocket payments (OOP)
and it was the principal means of financing health care in Nepal.15 This is commonly seen in
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other low-to-middle income countries (LMIC) where there is a higher proportion of OOP and
lower proportion of federal spending. Nepal’s healthcare has also heavily relied on foreign
aid such as non-governmental organizations and international aid,14
Additionally, under this new constitution, Nepal has stated and addressed that health
is a fundamental human right, and all citizens have the right to access basic healthcare
services that are free of cost.12 Evidently in reality, there are many geographic and socioeconomic barriers towards access to care in Nepal which makes it very difficult to provide
equitable care. In the total population, approximately only 60% of the population have access
to a health facility within 30 minutes. However, disparity is observed when we compare
urban populations (85.9%) with rural populations (59%) for access to a reasonably close
health facility.14 It often may take hours for patients in villages or mountainous regions to
travel to their closest health clinic and some patients may even need to travel more than 100
kilometers away.10,16 Most private hospitals and pharmacies are concentrated in the central
region of Nepal (most developed region), while the western region (less developed region)
has no private hospitals.14 If Nepalis need access to a specific healthcare service, they will
likely pay out-of-pocket at a private institution which creates a financial barrier to many rural
populations.14
Further, eye specialists are not common in general practice, and they often work in
specialized eye hospitals or clinics, making access to eye care even more difficult. The
ophthalmologist and optometrist to population ratio is very low in Nepal (ophthalmologist
1:193,900; optometrist 1:791,700) and eye care is very underserviced.10 The WHO goal and
norm for eye care is 1:100,000 for both ophthalmologists and optometrists.10
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Therefore, outreach services to rural Nepal, often funded by non-governmental
organizations, have arisen and many Nepalis may have access to temporary village-level
primary eye care centres known as “diagnostic-screening and treatment camps” or “eye
camps”.10,17,18 The implementation of eye camps in villages aim to reduce both the
geographic and economic burden for these rural populations.
These eye camps follow the Aravind Model which make use of trained healthcare
professionals or tele-ophthalmology with eye hospitals and ophthalmologists in Nepal.17,19,20
A team of ophthalmic assistants (OA), ophthalmic technicians (OT), or nurses make a day
trip to a village in Nepal and provide basic eye care and examinations to patients. Often, the
OA will identify and diagnose patients with cataracts and refer them to see an
ophthalmologist at the base hospital.10,17 However, the agreement of a cataract diagnosis
between an OA with an ophthalmologist is moderate (kappa = 0.623)11, and the OA’s
diagnostic accuracy for identifying cataracts is also moderate (specificity = 0.838)19. As a
result, there may be many patients with cataracts who do not receive a timely diagnosis or
referral to an ophthalmologist in Nepal. Additionally, current eye camps are often described
as “hectic” because the eye camps service hundreds of patients a day and many workers
experience occupational burnout in these conditions.11
Currently, there are various machine learning (ML) classifiers that can automatically
detect and diagnose cataracts.21 ML classifiers have been proven to show high diagnostic
accuracy for correctly identifying cataract and non-cataract cases, and these algorithms have
proven to be a powerful diagnostic tool that clinicians have begun to use.22–24 In urban
contexts, there are many benefits to using a ML screening program as it can reduce the
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workload of healthcare providers, reduce the burden and wait times of the eye clinics, and
also provide patients with a fast and accurate cataract diagnosis.25–29 These advantages may
translate into rural eye camps and rural settings.

4.1.1 Objective
The objective of this study was to conduct a cost-effectiveness analysis (CEA) of the
theoretical implementation of a ML-based cataract screening eye camp in rural Nepal in
order to assess if this new technology was superior to the traditional eye camps. Our primary
interest was to evaluate the additional cost per correctly detected case from a healthcare
perspective to assess if the program could improve the detection of cataract and non-cataract
patients.

4.2 Methods
This study followed the Consolidated Health Economic Evaluation Reporting
Standards (CHEERS) checklist (Appendix I).30

4.2.1 Study Setting and Population
This cost-effectiveness analysis was developed to fit the Chitwan and Nawalparasi
Districts of South-central Nepal which are located within the Lumbini and Narayani Zones,
respectively. The total population of the Chitwan and Nawalparasi Districts was
approximately 1,223,492 according to the 2011 National Census, and this population
represented 20.9% of the total population in the Lumbini and Narayani Zones.10,16 The
Bharatpur Eye Hospital was used as the base hospital for this study, and it is in the border of
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the two districts. The base hospital functions as a central location where the eye camps stem
from, and most of the employees at the eye camps are also employed from the base hospital.
Often, the ophthalmologist at the base hospital will be involved with referral triage,
treatment, and follow-up of the patients from the eye camps.
The adult cataract population was the study’s main interest (aged 20 or older), and
only participants who were screened by an eye camp in these regions were included
(n=22,805).10

4.2.2 Model Design
A decision tree was constructed using TreeAgePro Suite 2022 R1.0 (TreeAge
Software, Inc, Williamstown, Massachusetts) to compare the traditional diagnostic and
screening eye camps and machine learning-based eye camps (Figure 4.1). Variable inputs
and definitions are listed in Appendix J. In the decision tree framework, the implementation
of a machine learning assessment was assumed to be a fully automated system that replaces
the diagnostic assessment of an OA. There was a strength to assuming a fully automated
model in order to assess the full potential of an ML-based screening program.
The model’s health outcome of interest was the detection of any type of cataract in at
least one eye (<6/18 to 6/60 in worse eye and 6/60 in the better eye) in adults referrable to an
ophthalmologist in Nepal.18 These classifications are distance vision impairment scales, and
it refers to the severity of visual acuity in each eye. For example, 6/18 refers to the patient’s
ability to see clearly at 6m what should normally be seen at 18m distance. This diagnostic
outcome was chosen because it is consistent with both the diagnostic criteria set by
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Venkataswamy et al., Cheung et al., and the Nepal Blindness Survey Guideline.9,19,21
Additionally, this CEA was conducted from a third-party healthcare perspective, and it was
tailored to have a health policy and program implementation focus. Current eye camps that
exist in Nepal and surrounding regions are often funded by non-governmental organizations
which run the camps for non-profit. Therefore, to mimic reality, a narrower viewpoint was
utilized to include costs incurred by third-party organizations that would implement machine
learning into existing eye camps. The effectiveness measure used for the CEA was the cost of
an accurately ‘detected case’ of cataract and non-cataract.31

4.2.3 Interventions
Traditional eye camp (Arm 1)
We designed this economic model for patients in the rural areas and villages of the
Chitwan and Nawalparasi Districts in Nepal where eye hospitals and or clinics were not
easily accessible to patients. In a typical eye camp, pamphlets, radio announcements, and
verbal support from village leaders are implemented to promote and publicize the operation
of the eye camps on the designated day of visit. The typical eye camp uses the Aravind
model where a team of OA, OT, and nurses are hired for the duration of the camp. In the
camps, the OA conducts a simplified eye examination and a referral to an ophthalmologist at
the base hospital was given if any cataract was detected.
Cataract patients who were referred to an ophthalmologist receive transportation to
Bharatpur Eye Hospital if they consented to further assessment and treatment.1013,15 Patients
who received a true-negative or false-positive diagnosis by the OA are considered to be free
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of cataracts. There are substantive health related implications for patients who are given a
false negative result because they are then living with an undiagnosed cataract which can
result in a lower quality of life due to lowered visual acuity.
ML-based eye camp (Arm 2)
The ML-based eye camp model resembled the traditional eye camp model in terms of
logistics and operations, location, and publicity. The ML-based eye camp required a slit-lamp
microscope, and ML software to process the slit-lamp images. In this model, we followed the
feasibility of eye camps from Kandel et al. and assumed 75 eye camps operated in one year,
which employed one OA and one nurse to take slit-lamp photos of the patient’s eyes.10 The
ML algorithm instantaneously provided the OA and patient a result of whether they were
positive or negative for cataracts. Patients who received a positive diagnosis would receive a
referral to an ophthalmologist at the base hospital. It was assumed that all images taken by
the OA were readable by the algorithm.32

4.2.4 Model Probabilities and Cost Data
The base-case model probabilities are shown in Table 4.1. The prevalence of any
cataract (8.5%) in the Nepali population was retrieved from the 2011 Nepal Blindness
Survey.9 Based on a study by Soellener & Koenigstorfer, the authors found that patient
compliance with a machine learning diagnostic program is higher than human assessment.33
Therefore, for the purposes of this model, we assumed that there was full patient compliance
to ML assessment – this followed our assumption for a fully automated model. We also
assumed full patient compliance to the traditional eye camp arm. The population at the root
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node of the decision tree were patients who signed up and consented to be screened at an eye
camp.
Estimates for the diagnostic accuracy of ML classifiers were obtained by our metaanalysis (Chapter 03) which reported the pooled sensitivity and specificity values from 9
studies.21 The study investigated the diagnostic performance of ML classifiers for cataracts,
and the authors computed the estimated pooled sensitivity and specificity values. Another
study by Venkataswamy et al. was used to retrieve the diagnostic performance of OA for
diagnosing cataracts under the Aravind model.19
Data sources for estimates of cost included published literature and official
government reports. Direct costs were incorporated into our analysis and the costs were
adjusted to 2021 USD. The total costs of 75 eye camps are estimated in Table 4.2 and the
ranges used for the sensitivity analysis. Due to the implementation of ML, we assumed that
there would be a reduction in the need of workers at the ML-based eye camps compared to
the traditional eye camp labour and therefore a reduction in the labour costs ($683.42 vs
$1847.37).10 These costs were retrieved and estimated from the costs reported by Kandel et
al. when there was a reduction from four staff working at the eye camp to two staff based on
varying eye camp models.10 In past Aravind camp models, only two workers were employed
at the eye camps, therefore it is feasible to assume that one OA and one nurse were hired per
ML-based eye camp.10 Additionally to the salary for OA and nurses, a wage supplement was
included to the total labour costs in the analysis. The purpose of the wage supplement is to
incentivize the OA and nurses who regularly work at the base hospital to take part in working
at eye camps that may be in a more rural and distant location than the hospital.
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Based on literature, we did not include start-up costs with the development of the
algorithm in the model – these assumptions were fair and had been utilized in other studies. 32
Further, it was assumed that within the equipment and other consumable costs, a slit lamp
microscope, and computer with a compatible software for ML was included. Logistical costs
in both types of camps were fixed which includes both publicity and transportation costs. The
eye camps in the villages in Nepal are often temporary, one-day camps which requires
publicity and promotion to the villages in advance. Health promotion is crucial to rural
populations for them to understand the importance of eye care management and to utilize
these eye services.10,19 Transportation costs include the vehicle and cost of gas to transport
the equipment and staff between villages and to the base hospital.10 The cost of running an
eye camp was the total cost of labour, capital, and logistical expenses.

4.2.5 Effectiveness Measures
There were two effectiveness measures that were of interest to this study: (1) the
probability of a true positive (tp) cataract case correctly detected and (2) the probability of
the of a tp cataract cases or true negative (tn) non-cataract cases correctly detected by the OA
and ML classifier. These proportions were calculated by taking the probability of the
screened patient population being truly positive or negative for cataracts and receiving a true
or false diagnosis. An incremental cost-effectiveness ratio (ICER) was calculated and
generated to assess the cost associated with an additional correctly detected (1) case of
cataract or (2) case of cataract and non-cataract after the implementation of the ML
assessment.
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4.2.6 Deterministic Sensitivity Analysis
Variable parameters included in the model that were considered as drivers were
included in the sensitivity analyses. Each variable had an effect measure, and ranges were
applied to the variables either based on their 95% confidence intervals, or an upper and lower
25% limit was applied. The sensitivity analyses only reported the cost per correctly detected
case (true cataract and non-cataract case) per year. One-way sensitivity analyses were
conducted in order to assess each variable’s uncertainty to the model outputs. Additionally,
multiway sensitivity analyses with combined model variables were also analyzed to generate
extreme cases.

4.3 Results
4.3.1 Base-case Analysis
The base-case analysis considered a total population of 22,805 patients who were
screened at one of the 75 eye camps over the period of one year in Nepal. The ML-based eye
camp could correctly detect an additional 31 cases of cataract (tp), and 2546 additional cases
of non-cataract diagnosis (tn) (Table 4.3). In total, the ML-based eye camp can identify 2577
additional correct cases. The average cost-effectiveness ratios per cataract case detected were
$23.87 with the ML-based eye camps and $45.89 with the traditional eye camps; the cost per
correctly detected case was $0.24 and $0.51 respectively (Table 4.4). In both costeffectiveness analyses, the traditional eye camp was absolutely (strongly) dominated, this
demonstrated that the ML-based eye camp was the more cost-effective method than the
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traditional eye camp (Figure 4.2). The traditional eye camp is said to be dominated because
it is more costly and identifies less correctly detected cases compared to the ML eye camps.

4.3.2 Sensitivity Analysis
One-way sensitivity analysis
The sensitivity analysis evaluated a range of model parameters including the
prevalence of cataracts in Nepal, the diagnostic accuracy of ML classifiers and OA, and the
labour and capital costs of eye camps. The multiple one-way deterministic sensitivity
analysis results are outlined in Table 4.5 and presented as a tornado diagram (Figure 4.3). A
one-way sensitivity analysis was conducted for every input in the decision tree and 17
intervals were used to assess the change in ICER and dominance from the lower to upper
bound of each parameter’s uncertainty. The tornado diagram was plotted to visually display
the results from Table 4.5 – the ICER tornado reports the range of ICERs generated for each
parameter’s uncertain range. Overall, the one-way sensitivity analysis demonstrated that all
parameters were stable in all variations, and no variables changed the outcome that MLbased eye camps were the most cost-effective program option.
We observed that the parameter of greatest uncertainty for the model was the cost of
labour in the traditional eye camps ($2,444.94 to $4,074.89) which ranged from $0.44 to
$0.57 per correctly detected case in traditional eye camp (Table 4.5). The next greatest
uncertainty for the one-way analysis was the specificity of ML classifiers, and then the cost
of labour in ML eye camps. However, it was observed that all one-way sensitivity scenarios
continued to favour the ML-based eye camps as it was the dominant approach in all intervals
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of the analysis. To test the parameters of diagnostic accuracy of the OAs and ML classifiers,
we used the lower and upper 95% confidence intervals into the analysis which continued to
demonstrate ML as undominated.
Another important parameter that may influence the analysis is the prevalence of
cataracts in Nepal. Based on the 2011 Nepal Blindness Survey, the prevalence of cataracts in
the entire population is around 8.5%.9 However, it is acknowledged that there may be varying
distributions and prevalence of cataracts in different regions within a country such as the
Chitwan and Nawalparasi districts. The one-way sensitivity analysis evaluated the lower and
upper bounds of the cataract prevalence rate (6.63% to 10.63%) and found that the ML eye
camps continued to be the cost-effective intervention at $0.23 to $0.25 per correctly detected
case, respectively.
Two-way and multi-way sensitivity analysis
A two-way sensitivity analysis was also conducted to estimate any joint influences
that two parameters may have together on the cost-effectiveness analysis. We considered
multiple joint parameters including the cost of traditional and ML eye camp labour, and the
sensitivity of OA and ML classifiers. Similar to the one-way sensitivity analysis, all two-way
scenarios demonstrated that ML-based eye camps were dominant (Appendix K).
We also conducted a multi-way analysis to produce an extreme scenario case analysis
where we varied the multiple parameters at once. The parameters for the variables used for
each scenario are outlined in Appendix L. In the best-case scenario for ML eye camps, the
diagnostic accuracy of ML classifiers was set to the upper 95% CI (sensitivity = 0.987,
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specificity = 0.980), and the diagnostic accuracy of OAs was set to their lower limits
(sensitivity = 0.909, specificity = 0.830). The labour and capital costs of ML-based eye
camps were set to their lower limits, while the labour and capital costs of traditional eye
camps were set to their higher bound. In the best-case scenario, ML-based camps remained t
dominant with the ICER being -$0.89 per additional case detected.
Alternatively, in the worst-case scenario for ML eye camps, the diagnostic accuracy
of ML classifiers was set to the lower limits (sensitivity = 0.924, specificity = 0.815), and the
diagnostic accuracy of OAs was set to their upper limits (sensitivity = 0.942, specificity =
0.858). Labour and capital costs of the ML-based eye camps were also set to their upper
limits, and traditional eye camps was set to their lower limits. In the worst-case scenario, the
ICER was $1.21 and there was no dominance in either strategy. Only in this worst-case
scenario did we find that the ML eye camps were less effective, but less costly.

4.4 Discussion and Conclusion
To the best of our knowledge, this study is the first to economically evaluate the use
of ML classifiers for cataract diagnosis.32,34 The analysis showed that the ML-based eye
camps could have lower personnel costs (and in total costs), while detecting more correctly
diagnosed cases. While the ML-based eye camp was able to identify 31 additional cases of
cataract in the Nepali population, its power and effectiveness came from its ability to
correctly identify an additional 2546 of patients without cataracts that would have been overdiagnosed in a traditional eye camp.
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Further, the one-way, two-way, and best-case multiway analysis demonstrated that
despite the influences of branch probabilities and costs, ML-based eye camps remain to be
the cost-effective strategy. In these specific instances, the negative ICER value depicts that
ML-based eye camp was more effective, and less costly; the ICER lies in the southeast
quadrant within the cost-effectiveness plane because the ML eye camps were less costly and
more effective. Whenever an alternative lies in the southeast quadrant, that intervention is
always accepted.35,36 Only in the worst-case multiway sensitivity analysis did we find that the
ML-based eye camps and traditional camps to have no dominance given by an ICER of
$1.21. In this worst-case scenario, the ML eye camps were less effective than the traditional
camps due to its lowered sensitivity and specificity, however it still demonstrated to be less
costly. Both the sensitivity and specificity of the ML eye camps were lower than the
traditional camps which suggest that overall, the screening program would detect fewer tn
and tp cases. The worst-case scenario for the ML eye camps would be in the southwest
quadrant of the cost-effectiveness plane which implied there may be a trade-off between the
eye camps.35
Eye care services in rural Southeast Asia is scarce, and blindness from cataracts
continues to be a pervasive issue due lack of access to eye care services in villages and
mountainous regions.4,6,37,38 A more timely and quick diagnosis of cataracts in rural Nepal
can provide patients with better management and treatment of cataracts, and thus lead to an
improved quality of life with vision. Although large efforts in Nepal have been made
through the implementation of eye camps in the past few decades, the additional
implementation of ML may further reduce labour costs, reduce healthcare worker burnout at
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the camps, and could provide diagnostically accurate results for patients.25,39,40 Additionally,
evaluating the reduced wait times, workload, and patient satisfaction of rural eye camps may
be warranted in future studies to assess the full benefits of ML.
Our study should be interpreted within the context of certain limitations. First, the
probabilities and assumptions used in the decision tree is based on the current availability of
the literature and some uncertainties may exist due to the scarce information on health
economics of the use of artificial intelligence.34 Due to low literacy rates and low levels of
education among the population in Nepal, patients may not fully understand or be compliant
to the use of ML and there may be hesitancy or low adherence to the ML assessment.16
Therefore, it is important for patients in the ML eye camp arm to be educated on ML derived
medical decisions in order to gain trust and patient compliance.33 The uncertainties for the
model inputs and variables were attempted to be remedied by the multiple sensitivity
analyses conducted.
Further limitations related to the uncertainties were the choice of sensitivity analyses
conducted for this study. A one-way, two-way, and multi-way sensitivity analysis were
included in this paper; however, a probabilistic sensitivity analysis (PSA) was not used. PSA
is a method for accounting parameter uncertainty where samples are repeatedly drawn from
each distribution to be used as the decision inputs.41,42 The benefit of using PSA is that it
explores joint uncertainty (ie. uncertainty resulting from all parameters simultaneously). In a
future cost-effectiveness analysis for ML implementation, PSA can be used as the preferred
analysis for parameter uncertainties.41 Also, another limitation, for the sensitivity analysis in
this paper, we applied an upper and lower 25% bound for the probability and cost inputs.
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The sensitivity and specificity values of the ML classifier that were retrieved from
Chapter 03 was also subject to limitations in this study. The ML diagnostic accuracy values
from the meta-analysis were an aggregate of all imaging modalities available from the
literature which included slit-lamp, fundus, and visible wavelength images. For the MLbased eye camp model in this study, we assumed that only slit-lamp microscopy was
performed for each patient to take an image of the anterior segment of the patients’ eyes.
Therefore, there may be limitations that exist in those results due to the heterogeneous nature
of the diagnostic performance of ML. In future analysis, we hope that there are more
diagnostic accuracy studies of ML classifiers that uses slit-lamp images in order for a
subgroup meta-analysis with sufficient power to be conducted.
Additionally, this CEA took on a health policy and program implementation
perspective, therefore the effectiveness measure was the ability to identifying a correctly
detected case (tp and tn). In future studies, it would be beneficial to also assess the visual
deterioration in these patients by considering their quality-adjusted life year measure in order
to assess the full effectiveness of the ML-based eye camps.
The results of this study may only be able to capture rural locations where access to
eye care services is extremely limited, and there is no public insurance or health coverage for
these types of ophthalmic services. Additionally, the population and regions that this study
considers was the Chitwan and Nawalparasi Districts of South-central Nepal, so the results
may not be generalization. However, this methodology could be applied for the provincial
level if respective data is gathered. Therefore, further studies can assess the ability to
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implement ML classifiers for cataracts outside of the eye camp framework, and into other
clinics and locations in semiurban to urban regions.
In conclusion, the results of this study demonstrated the practical and economic
feasibility for a ML-based screening program to be implemented in existing eye camps in
rural Nepal over the existing eye camp models. The implementation of ML in the Aravind
eye camps may be utilized in other rural regions and LMICs. Both the patients and healthcare
workers at the eye camps could benefit from the implementation of this program, and
healthcare organizations in Nepal could consider investing in this type of program because of
its cost savings.
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4.6 Tables and Figures
Table 4.1 Base case model parameters and parameter ranges
Parameter

Value

Range

Fixed Data elements
Patients screened in study setting10

22,805 patients

-

-

Patient compliance to OA-based
decision30

100%

-

-

Patient compliance to AI-based
decision30

100%

-

-

8.50%

6.38%

10.63%

Sensitivity

0.948

0.815

0.987

Specificity

0.96

0.924

0.98

Sensitivity

0.932

0.909

0.942

Specificity

0.838

0.83

0.858

Variable data elements
Prevalence of any cataract in Nepal9
ML assessment parameters17

OA parameters15
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Table 4.2 Estimated costs for traditional eye camps and ML-based eye camps
Item

Cost of
Traditional
DST Camp

Range

Cost of AIbased DST
Camp

Range

Salary for OA and Nurses

$1,847.37

$1,385.53 $2,309.21

$683.42

$512.57 $854.28

Wage supplement for OA and nurses
for rural initiative

$1,412.54

$1,059.40 $1,765.68

$711.30

$533.47 $889.12

Equipment and other consumables

$116.56

$87.42 - $
145.70

$116.56

$87.42 $145.70

Maintenance, repairs, insurance

$629.52

$472.14 $786.90

$629.52

$472.14 $786.90

Publicity

$262.97

-

$262.97

-

Transportation

$1,895.72

-

$1,895.72

-

Total Costs

$6,164.69

Labour Costs

Capital Costs

Logistical Costs

$4,299.49
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Table 4.3 Diagnostic test outcomes of traditional eye camps and ML-based eye camps per
22,805 patients in the study model
Traditional eye camp
(OA Assessment)

Measure

ML-based eye camp (ML
Assessment)

Total patients screened

22805

22805

True-positive (tp) result

1807

1838

True-negative (tn) result

17486

20032

False-positive (fp) result

132

101

False-negative (fn) result

3380

835

Table 4.4 Incremental cost-effectiveness results for traditional eye camps vs ML-based eye
camp
Eye camp

Cost per
patient
($)

Increme
ntal cost

Effectiveness
(probability
of a case
detected)

Incremental
effectiveness

Cost
effective
ness

ICER

Dominance

Cost per cataract case detected (true-positive cases)
ML-based
eye camp

0.189

Traditional
eye camp

0.288

0.006493

0.099

0.006276

23.87

-0.000217

45.89

Undominate
d
-457.76

Absolutely
dominated

Cost per case correctly detected (true-positive and true-negative cases)
ML-based
eye camp

0.189

Traditional
eye camp

0.288

0.777

0.099

0.567

0.243

-0.210

0.510

Undominate
d
-0.475

Absolutely
dominated
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Table 4.5 One-way deterministic sensitivity analysis results

Range

ICER ($/case
correctly detected)

0.085

0.0638 to 0.1063

-$0.40 to -$0.51

Sensitivity

0.932

0.909 to 0.942

-$0.47 to -$0.48

Specificity

0.838

0.830 to 0.858

-$0.45 to -$0.57

Sensitivity

0.948

0.815 to 0.987

-$0.48 to -$0.47

Specificity

0.96

0.924 to 0.980

-$0.67 to -$0.41

Parameter
Prevalence of any cataract

Base-case
Value

Diagnostic accuracy of ophthalmic
assistants

Diagnostic accuracy of machine
learning classifiers

Labour Costs
Traditional Eye Camp

$3,259.91

$2,444.94 to $4,074.89

-$0.29 to -$0.66

ML-based Eye Camp

$1,394.72

$1,046.04 to $1743.40

-$0.55 to -$0.40

Capital Costs
Traditional Eye Camp

$746.08

$559.56 to $ 932.60

-$0.43 to -$0.52

ML-based Eye Camp

$746.08

$559.56 to $ 932.60

-$0.51 to -$0.44
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Figure 4.1 Decision tree showing the competing alternatives for cataract diagnosis and screening camps. Arm 1 illustrates the traditional
eye camps; Arm 2 illustrates to the ML-based eye camps evaluated in the model. A square represents a decision node, a circle is a chance
node, and the triangle represents the terminal node.

115

Figure 4.2 Cost-effectiveness plane of traditional eye camps vs introduction of ML-based
eye camps. The traditional eye camp program is absolutely dominated by the ML-based eye
camps. The blue circle represents the traditional eye camps which is dominated, and the red
square represents the ML-based eye camps.
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Figure 4.3 Tornado diagram of the one-way deterministic sensitivity analysis with critical
variables. The vertical line represents the final ICER (-0.475). All the variables crossed the
final ICER value which demonstrates that none of the parameters disturbs the final result
from the base-case. The blue bar represents the change in direction from the baseline ICER
of the lower bound, and the red bar represents the change of the upper bound of each
parameter.
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CHAPTER 5
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5

Integrated Discussion

5.1 Overview
This chapter will discuss the interpretations and implications of the results from the
meta-analysis of diagnostic studies, and the health economic analysis of the implementation
of ML classifiers for cataract diagnosis. The objectives of this thesis were to (1) assess the
diagnostic accuracy of ML classifiers, and (2) use the findings from objective 1 to explore
the cost-effectiveness of ML assessment versus a traditional assessment in diagnostic and
screening eye camps in rural Nepal.

5.2 Integrated Discussion of Results
Chapter 03 was the first study that investigated the diagnostic accuracy of machine
learning classifiers for cataracts based on the current literature available. The study aimed to
systematically review the current body of knowledge for the types of machine learning
classifiers that researchers are using, and to meta-analyze the pooled sensitivity and
specificity of these classifiers. The most recent database search conducted by the review was
on September 12, 2021, and no limits were placed on the publication date of the studies.
Based on literature from both published and unpublished sources, 21 studies met the
inclusion criteria, and 11 of those studies were used for the meta-analysis. The primary
analysis of the study was investigating the adult cataract population, and a secondary analysis
(sub-group analysis) was conducted for the pediatric cataract population. In both analyses
through a hierarchical logistic regression, we observed high diagnostic accuracy in both the
sensitivity and specificity of machine learning classifiers. The summary estimate for
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sensitivity was 0.948 [95% CI: 0.815-0.987] and specificity was 0.960 [95% CI: 0.9240.980] for adult cataracts screening using a ML classifier. Additionally, similar results were
found for pediatric cataracts. Compared to the diagnostic accuracy of OA in eye camps
(sensitivity = 0.932, specificity = 0.838), the ML classifier outperforms the OA with higher
sensitivity and specificity.1 This suggests the potential for machine learning that could be
used to screening patients with cataracts in rural settings.2
Using the results obtained from Chapter 03, the cost-effectiveness analysis in Chapter
04 utilizes the pooled sensitivity and specificity of machine learning classifiers to be
implemented in eye camps in rural Nepal. These estimates and probabilities inserted into the
decision tree was suitable for the model because all studies were identifying for “any
cataract” (<6/18 to 6/60 in the worse eye and 6/60 in better eye).3 Specifically, in the
Chitwan and Nawalparasi Districts of Nepal, existing eye camps have been implemented in
the past few decades In order to provide rural Nepalis with eye care services.4 The CEA in
Chapter 04 demonstrated that ML provides a cheaper and effective outcome over the
traditional eye camp Aravind model. Sensitivity analyses were conducted to consider the
variability of certain parameters included in the economic model.
We observed that the use of ML in eye camps in rural Nepal can identify 2577
additional correct cases. The cost per correctly detected case was $0.24 and $0.51 for the
ML-based and traditional eye camp, respectively. The sensitivity analyses showed that in all
scenarios except the worse-case scenario, ML-based eye camps were dominant. The
assumption that a fully automated ML assessment in the current population could be likely
because OAs are burning out in their current working conditions and eye care specialists are
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almost non-existent in these rural and mountainous regions.5,6 The ICER was negative in all
cases which suggests that we could accept this form of eye care delivery.7 This study shows
the potential and the feasibility for this type of technology to be implemented in rural Nepal.

5.3 Thesis Limitations
Brief limitations of each study were discussed in Chapter 03 and Chapter 04
respectively, but this following section provides additional limitations to consider in both
studies.

5.3.1 Limitations in Chapter 03
Firstly, the limitation of a meta-analysis exists in its inclusion criteria and there are
inherent biases in observational studies that could exist as stated by Egger et al.8 In the body
of literature in ML diagnosis for cataracts, there is a limited number of studies published,
thus we included all studies regardless of risk of bias domains being scored as medium or
high in the QUADAS-2 tool. Fortunately, all 21 included studies generally presented with
low risk of bias, with only a few studies receiving a medium or high risk of bias in the ‘flow
and timing’ and ‘patient selection’ domains.9
Additionally, as mentioned in Chapter 03, a random-effects model was utilized for the
meta-analysis due to the high heterogeneity found across studies. Heterogeneity across the
studies could exist due to location of the study (geographical locations), varying effect sizes
across studies, precision of each effect size, methodology of each study, and study design.8,10
It is noted, however, that regardless of the heterogeneity found from the analysis, a randomeffects model would have been utilized.
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In our statistical analysis, all types of ML classifiers were included and aggerated.
Each type of algorithm has different methodological considerations. Additional subgroup
analysis could be conducted if there were more studies found and included in the metaanalysis for each type of classifier. Future research could focus on sub-group analysis by type
of ML classifier. We included both slit-lamp imaging and fundus imaging in our analysis,
and we recognize that the types of images used to train an algorithm could be different.

5.3.2 Limitations in Chapter 04
As mentioned in Chapter 04, this study was the first CEA of any diagnostic ML
algorithm for cataracts and there is limited availability of literature, thus assumptions were
made to develop the economic model. We assumed that all images that were taken by the
slit-lamp microscope were readable by the algorithm. An error can occur when the algorithm
cannot produce an output because the images are blurry and cannot detect an image properly.
The assumption was that the ophthalmic nurses or OA were properly trained, which would be
the case, to take clear images to input them into the algorithm and would retake an image if
done improperly. Due to the high demand for eye care services in villages, we assumed that
patients would be compliant with a machine learning assessment as an OA assessment.11
In addition, we took a health policy and program implementation approach for this
analysis, thus the effectiveness measured the number of cases correctly detected. This clinical
outcome describes an intermediate end point for economic studies. Typically, life-years
gained, and quality of life measures are used as final end point outcomes, to assess the
patient’s benefits or burdens by the program or intervention.12 The critique in having an
intermediate end point in a CEA is the difficulty of establishing a relationship between the
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intermediate and final end points. However, as stated by Drummond et al., there may be
value in an intermediate end point for diagnostic tests when a long-term cost-effectiveness
may be achieved from the intermediate outcome.12
Further, this study did not consider the patient-specific benefits of implementing an
ML-based eye camp such as decreased patient wait times, decreased patient anxiety, stress
and burden, increased patient productivity and economic opportunity, and quick and accurate
diagnostic outcome.13–15
For this study, we only considered rural regions for the implementation of ML
classifiers due to the existing nature of temporary eye camps. It may not be feasible to
implement this program in locations such as Ontario where the public health insurance
covers annual eye examinations for certain groups of people.

5.3.3 Limitations in the Applications of Artificial Intelligence
Although there is great potential for AI, there are also pitfalls in the use of these
algorithms in the healthcare setting including algorithm bias. Algorithm bias and data privacy
are examples are the increasing concerns with the full implementation of AI and ML in
healthcare settings.16,17
Algorithm bias refers to the unwarranted skewing of the output results of an
algorithm due to problems from the initial algorithm development and design.18,19 The type
of data that the algorithm is being taught and validated can make a large impact on the output
that the algorithm produces. 17,18,20 Algorithm bias presents as a critical consideration when
implementing AI technologies into the healthcare setting because there are evident examples
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of discrimination and bias of race, sex, and socio-economic status in the algorithm’s
outputs.21 These biased (and perhaps discriminatory) outputs may exclude certain
intersections of patients from receiving a necessary treatment or intervention and can prevent
certain groups of people to have reasonable access to insured hospital and physician services,
simply due to the inadequate dataset that is initially inputted into the algorithm.21 If these
people are discriminated against by the algorithms, then there are barriers to their access to
care and health services.22
Commonly, a working algorithm can be sold or shared globally without considering
the source of the training inputs.23 Therefore, an AI algorithm that is developed and trained in
one country can be used in another country with different patient characteristics and
demographics. This presents a critical challenge when implementing an algorithm in the
healthcare setting because the algorithm can provide an inaccurate diagnosis of a certain
disease for a population of a different race, ethnicity, or body type.18,23
However, there is added strength in the sensitivity and specificity estimates that were
obtained from the meta-analysis because the meta-analysis included studies that contained
databases of populations that many come from the neighbouring countries of Nepal such as
China and India. The included studies come from these Asian countries, which may increase
the validity of our results to the Nepali population.
Additionally, this study tries to remedy the issues of algorithm bias through the
distribution of benefits and burdens of the diagnostic outcomes and probabilities. A term
called “distributive justice” is common in the realm of algorithm bias when referring to
having action towards fairness — this can in the form of modification, adjustment, and
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redress of the algorithm.21 In order to clearly outline the benefits or burdens of a diagnostic
algorithm, a single accuracy proportion does not suffice. Often in many diagnostic accuracy
studies of ML classifiers, only the F-score or F1-score is reported as the accuracy value for
the classifier.21 The F-score is a function of the positive predictive value (PPV) and the
sensitivity which are derived from the tp, fp, and fn values. Therefore, the tn value is often
disregarded in many accuracy studies of ML classifiers and it can bring a very important
insight on the effectiveness of the screening program as a whole. Reporting all the true
negative, true positive, false negative, and false positive values is very beneficial for policy
driven data because it considers all aspects of the diagnostic accuracy.19 This allows for the
data to be transparent, and values have been clearly outlined throughout the thesis in both
Chapter 03 and Chapter 04.

5.4 Conclusions and Future Directions
In conclusion, this thesis found that ML classifiers are more diagnostically accurate
for cataracts than ophthalmic assistants and the implementation of a ML-based eye camp is
more cost-effective than traditional eye camps in rural Nepal. Due to the high heterogeneity
of the meta-analysis, and the assumptions made for the CEA, we should be cautious of the
results. It may be feasible for existing eye camps in rural regions to implement ML in their
eye camps if there is a safe and approved ML algorithm publicly available for cataracts.
Health policymakers and healthcare organizations could continue to consider the benefits of
digital medicine, and the positive impact that it can have on both the healthcare and patient
perspective. In addition to the current guidance and implementation of ML for cataracts in
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the standard clinical setting, this thesis emphasizes the potential, feasibility, and need for ML
classifiers to be expanded to other ocular diseases.
Although this thesis has identified gaps in the literature, and it has summarized the
current body of literature on all ML classifiers for cataracts, there is still research and further
investigations warranted. When there exists more research on ML classifiers and their
diagnostic performance, further studies with multiple sub-group analyses based on ML
classifier type and imaging modality can evaluate which presents the highest accuracy. It is
also encouraged for future authors to report their tn, tp, fp, and fn values for the results to be
properly aggregated by the meta-analysis if possible. Additionally, the CEA is applicable
towards rural eye camps. Therefore, future economic analysis may be interested in testing the
feasibility of ML being implemented in more urban areas in order to evaluate whether the
benefits seen in villages are equivalent.
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APPENDICES
Appendix A: PRISMA Checklist
Section/topic

# Checklist item

Reported
on page #

TITLE
1

Identify the report as a systematic review, meta-analysis,
or both.
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2

Provide a structured summary including, as applicable:
background; objectives; data sources; study eligibility
criteria, participants, and interventions; study appraisal
and synthesis methods; results; limitations; conclusions
and implications of key findings; systematic review
registration number.

n/a

Rationale

3

Describe the rationale for the review in the context of what
is already known.

51

Objectives

4

Provide an explicit statement of questions being
addressed with reference to participants, interventions,
comparisons, outcomes, and study design (PICOS).

52

Protocol and
registration

5

Indicate if a review protocol exists, if and where it can be
accessed (e.g., Web address), and, if available, provide
registration information including registration number.

52

Eligibility criteria

6

Specify study characteristics (e.g., PICOS, length of
follow-up) and report characteristics (e.g., years
considered, language, publication status) used as criteria
for eligibility, giving rationale.

52

Information
sources

7

Describe all information sources (e.g., databases with
dates of coverage, contact with study authors to identify
additional studies) in the search and date last searched.

53

Search

8

Present full electronic search strategy for at least one
database, including any limits used, such that it could be
repeated.

54

Study selection

9

State the process for selecting studies (i.e., screening,
eligibility, included in systematic review, and, if applicable,
included in the meta-analysis).

54

Data collection
process

10

Describe method of data extraction from reports (e.g.,
piloted forms, independently, in duplicate) and any
processes for obtaining and confirming data from
investigators.

54

Title

ABSTRACT
Structured
summary

INTRODUCTION

METHODS
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Data items

11

List and define all variables for which data were sought
(e.g., PICOS, funding sources) and any assumptions and
simplifications made.

56

Risk of bias in
individual studies

12

Describe methods used for assessing risk of bias of
individual studies (including specification of whether this
was done at the study or outcome level), and how this
information is to be used in any data synthesis.

55

Summary
measures

13

State the principal summary measures (e.g., risk ratio,
difference in means).

56

Synthesis of
results

14

Describe the methods of handling data and combining
results of studies, if done, including measures of
consistency (e.g., I2) for each meta-analysis.

56

Section/topic

# Checklist item

Reported
on page #

Risk of bias
across studies

15

Specify any assessment of risk of bias that may affect
the cumulative evidence (e.g., publication bias, selective
reporting within studies).

56

Additional
analyses

16

Describe methods of additional analyses (e.g., sensitivity
or subgroup analyses, meta-regression), if done,
indicating which were pre-specified.

56

Study selection

17

Give numbers of studies screened, assessed for
eligibility, and included in the review, with reasons for
exclusions at each stage, ideally with a flow diagram.

57

Study
characteristics

18

For each study, present characteristics for which data
were extracted (e.g., study size, PICOS, follow-up
period) and provide the citations.

57

Risk of bias within
studies

19

Present data on risk of bias of each study and, if
available, any outcome level assessment (see item 12).

58

Results of
individual studies

20

For all outcomes considered (benefits or harms),
present, for each study: (a) simple summary data for
each intervention group (b) effect estimates and
confidence intervals, ideally with a forest plot.

59

Synthesis of
results

21

Present results of each meta-analysis done, including
confidence intervals and measures of consistency.

59

Risk of bias
across studies

22

Present results of any assessment of risk of bias across
studies (see Item 15).

58

Additional
analysis

23

Give results of additional analyses, if done (e.g.,
sensitivity or subgroup analyses, meta-regression [see
Item 16]).

60

24

Summarize the main findings including the strength of
evidence for each main outcome; consider their

61

RESULTS

DISCUSSION
Summary of
evidence
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relevance to key groups (e.g., healthcare providers,
users, and policy makers).
Limitations

25

Discuss limitations at study and outcome level (e.g., risk
of bias), and at review-level (e.g., incomplete retrieval of
identified research, reporting bias).

62

Conclusions

26

Provide a general interpretation of the results in the
context of other evidence, and implications for future
research.

63

27

Describe sources of funding for the systematic review
and other support (e.g., supply of data); role of funders
for the systematic review.

n/a

FUNDING
Funding

Appendix B: Database searches and keywords
Concept

EMBASE

MEDLINE

CINAHL

Keywords

Artificial Intelligence

Exp
artificial
intelligence/ or exp
machine learning/ or exp
deep
learning/
or
artificial neural network/

Exp
artificial
intelligence/ or exp
machine learning/ or
exp deep learning/ or
exp Neural Networks,
Computer

(MH
“Artificial
Intelligence+”) or (MH
“Deep Learning”) or
(MH “Neural Networks
(Computer)”) or (MH
“Machine Learning+”)

Artificial intelligence.mp. or
machine learning.mp. or
deep learning.mp. or neural
network.mp.

Diagnosis

Exp diagnosis/ or exp
prediction/

Exp diagnosis/

(MH “Diagnosis”)

Diagnos*.mp.
prediction.mp.

Cataract

Exp cataract/

Exp cataract/

(MH “Cataract”)

cataract.mp.

No Limits

110

40

19

Limit to Humans and
English Language

91

31

19

Appendix C. Search strategy and results for grey literature
ProQuest Dissertations & Theses
Searches

Results

noft(artificial intelligence) AND noft(diagnosis) AND noft(ophthalmology)

5

or
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Conference Searches
Conference

Link

Years searched

Search terms

Results/Comments

ARVO

https://arvojournals.org/solr/searchr
esults.aspx?q=meeting%20abstract
%20AND%20artificial%20intellige
nce%20AND%20cataracts&restype
id=1

All years

“meeting
abstract” AND
“artificial
intelligence”
AND “cataracts”

Searched through
meeting abstracts

23 results

AAO

https://secure.aao.org/aao/meetingarchive

All years

“artificial
intelligence”

Searched through all
meetings and scientific
posters

Event type: Paper

5 results
COS

https://www.cos-sco.ca/cpd/annualmeeting/

All years available

“artificial
intelligence”

Searched through
abstracts and
presentations

“machine
learning”
“diagnosis”

2 results

Appendix D. Kappa statistics calculation
Title and Abstract Screening
Review Authors

RC
Include

SS

Exclude

Unsure

Total

Include

22

2

0

24

Exclude

4

100

2

106

Unsure

0

5

0

5

26

107

2

135

Total

P0

0.903704

PE

0.657119
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kappa

0.719155

Full Text Screening
Review Authors

RC
Include

SS

Exclude

Unsure

Total

Include

18

0

0

18

Exclude

2

8

0

10

Unsure

0

0

0

0

20

8

0

28

Total

P0

0.928571

PE

0.561224

kappa

0.837209
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Appendix E. Simplified data extraction table
Study

Year

# Images
used

# Images
Labeled Normal

# Images Labeled nonnormal

Accuracy

Sensitivity

Sensitivity SD

Specificity
SD

Specificity

Acharya et
al.

2009

2520

1080

1440

0.9

0.977

1

Cao et al.

2020

1355

433

922

0.9483

0.9544

0.9353

Dong et al.

2017

7851

4671

2176

0.847

Guo et al.

2015

445

199

246

0.909

Huang et al.

2009

1000

0.914

Li et al.

2009

5820

0.95

Li et al.

2010

5850

0.95

Li et al.

2018

8030

0.972

Lin et al.

2019

350

243

107

0.874

0.897

0.864

Lin et al.

2020

2005

731

1274

0.81

0.79

0.02

0.82

0.04

2005

731

1274

0.79

0.78

0.03

0.81

0.03

0.9683

0.0002

0.9728

0.0001

Liu et al.

2017

886

476

410

0.9707

Pratap &
Kokil

2019

800

200

600

1

Ran et al.

2018

5408

1948

3460

0.9704

0.9726

0.9692
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SV&R

2018

228

100

128

0.9696

0.97

Wu et al.

2019

37638

4508

33130

0.8879

0.92

Xu et al.

2021

8030

2212

5818

86.24

0.9010

0.8495

Yang et al.

2016

1239

767

472

0.905

0.892

0.916

1239

767

472

0.899

0.89

0.907

0.9253

0.9484

Zhang et al.

2017

5620

3269

2351

0.9352

Zheng et al.

2014

460

158

302

0.9522

Zhou et al.

2020

1355

433

922

0.94

0.99
95% CI:
0.8733-0.9536

0.8385

95% CI:
0.7637-0.8971
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Appendix F. Results of the risk of bias assessment for studies included in the systematic
review using QUADAS-2 Tool
Domain 1

Domain 2

Domain 3

Domai
n4

Study

Risk of
Bias

Concerns
about
applicability

Risk of
Bias

Concerns
about
applicability

Risk of
Bias

Concerns
about
applicability

Risk of
Bias

Acharya et al. (2009)

unclear

low

low

low

low

low

unclear

Cao et al. (2020)

low

low

low

low

low

low

low

Dong et al. (2017)

low

low

low

low

low

low

low

Guo et al. (2015)

unclear

low

low

low

low

low

unclear

Huang et al. (2009)

low

low

low

low

low

low

low

Li et al. (2009)

low

low

low

low

low

low

low

Li et al. (2010)

low

low

low

low

low

low

low

Li et al. (2018)

low

low

low

low

low

low

low

Lin et al. (2019)

low

low

low

low

low

low

low

Lin et al. (2020)

low

low

low

low

low

low

low

Liu et al. (2017)

unclear

unclear

low

low

low

low

unclear

Pratap & Kokil
(2019)

unclear

unclear

low

low

low

low

unclear

Ran et al. (2018)

low

low

low

low

low

low

low

S V & R (2018)

low

low

low

low

low

low

low

Shimizu et al. (2021)

High

High

High

High

High

High

high

Wu et al. (2019)

low

low

low

low

low

low

low

Xu et al. (2021)

Low

Low

Low

Low

Low

Low

low

Yang et al. (2016)

low

low

low

low

low

low

low

Zhang et al. (2017)

low

low

low

low

low

low

low

Zheng et al. (2014)

low

low

low

low

low

low

low

Zhou et al. (2020)

low

low

low

low

low

low

low
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Appendix G. SROC Curve
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Appendix H. Hierarchical logistic regression results
Hierarchical Logistic Regression Results for Cataracts in Adults
Log likelihood = -104.8943

Number of ML classifiers = 9

---------------------------------------------------------------------|

Coef. Std. Err.

z P>|z|

[95% Conf. Interval]

-------------+-------------------------------------------------------Bivariate |
E(logitSe) | 2.908078 .7267127

1.483747 4.332409

E(logitSp) | 3.183793 .3507146

2.496405 3.871181

Var(logitSe) | 4.443394 2.541721

1.448133 13.63393

Var(logitSp) | 1.059711 .5134012

.4100188 2.73887

Corr(logits) | .0321894 .3461407

-.5695972 .6115086

-------------+-------------------------------------------------------HSROC

|

Lambda | 6.588162 .8886644
Theta | -1.261845 .6828454

4.846412 8.329912
-2.600197 .0765079

beta | -.716711 .3742015 -1.92 0.055 -1.450132

.0167104

s2alpha | 4.479614 2.383515

1.578821 12.71008

s2theta | 1.050054 .5113627

.4042848 2.727318

-------------+-------------------------------------------------------Summary pt. |
Se | .9482443 .0356649

.8151379 .9870344

Sp | .9602198 .0133965

.9238894 .9795914

DOR | 442.248 361.246

89.2011 2192.611

LR+ | 23.83709 8.105484

12.24091 46.4187

139
LR- | .0538998 .0371738

.0139485 .2082796

1/LR- | 18.55293 12.79565

4.801237 71.69223

---------------------------------------------------------------------Covariance between estimates of E(logitSe) & E(logitSp) .008058

Hierarchical Logistic Regression Results for Pediatric Cataracts
Meta-analysis of diagnostic accuracy
Log likelihood = -41.703961

Number of ML Classifiers =

-----------------------------------------------------------------------------|

Coef.

Std. Err.

z

P>|z|

[95% Conf. Interval]

-------------+---------------------------------------------------------------Bivariate |
E(logitSe) | 2.008967 .6020843

.8289034

E(logitSp) | 2.105182 .3449474

1.429097 2.781266

Var(logitSe) | 1.407823 1.03089

.3351572 5.913536

Var(logitSp) | .4422734 .356941

.0909328 2.151103

Corr(logits) | .5943803 .3564424

-.3763867

3.18903

.943022

-------------+---------------------------------------------------------------HSROC

|

Lambda | 4.315963 .8600888
Theta | -.6539444 .525611

2.63022 6.001706
-1.684123 .3762343

beta | -.5789356 .4568128 -1.27 0.205 -1.474272 .3164009
s2alpha | 2.516177 1.870604

.5860463 10.80315

s2theta | .1600326 .1334146

.031231

.820032

-------------+---------------------------------------------------------------Summary pt. |
Se | .8817353 .0627842

.696123 .9604194

4

140
Sp | .8914058 .0333914

.8067606 .9416551

DOR | 61.20009 51.78098

11.65618 321.3275

LR+ | 8.119543 2.862963

4.068147 16.20565

LR- | .1326721 .0733519

.0448917 .3920966

1/LR- | 7.537381 4.167278

2.550392 22.27583

-----------------------------------------------------------------------------Covariance between estimates of E(logitSe) & E(logitSp) .1171897

Appendix I: CHEERS Checklist
Topic

No.

Item

Location
where item
is reported

Title
1

Identify the study as an economic
evaluation and specify the interventions
being compared.

82

2

Provide a structured summary that
highlights context, key methods, results,
and alternative analyses.

n/a

3

Give the context for the study, the study
question, and its practical relevance for
decision making in policy or practice.

82

Health economic analysis
plan

4

Indicate whether a health economic
analysis plan was developed and where
available.

85

Study population

5

Describe characteristics of the study
population (such as age range,
demographics, socioeconomic, or clinical
characteristics).

85

Abstract

Introduction
Background and
objectives

Methods

141

Topic

No.

Item

Location
where item
is reported

Setting and location

6

Provide relevant contextual information
that may influence findings.

85

Comparators

7

Describe the interventions or strategies
being compared and why chosen.

85

Perspective

8

State the perspective(s) adopted by the
study and why chosen.

85

Time horizon

9

State the time horizon for the study and
why appropriate.

85

Discount rate

10

Report the discount rate(s) and reason
chosen.

84

Selection of outcomes

11

Describe what outcomes were used as the
measure(s) of benefit(s) and harm(s).

85

Measurement of
outcomes

12

Describe how outcomes used to capture
benefit(s) and harm(s) were measured.

85

Valuation of outcomes

13

Describe the population and methods used
to measure and value outcomes.

85

Measurement and
valuation of resources
and costs

14

Describe how costs were valued.

86

Currency, price date, and
conversion

15

Report the dates of the estimated resource
quantities and unit costs, plus the
currency and year of conversion.

86

Rationale and description
of model

16

If modelling is used, describe in detail and
why used. Report if the model is publicly
available and where it can be accessed.

87

Analytics and
assumptions

17

Describe any methods for analysing or
statistically transforming data, any
extrapolation methods, and approaches for
validating any model used.

85-90

Characterising
heterogeneity

18

Describe any methods used for estimating
how the results of the study vary for
subgroups.

91

Characterising
distributional effects

19

Describe how impacts are distributed
across different individuals or adjustments
made to reflect priority populations.

91

142

Topic

No.

Item

Location
where item
is reported

Characterising
uncertainty

20

Describe methods to characterise any
sources of uncertainty in the analysis.

91

Approach to engagement
with patients and others
affected by the study

21

Describe any approaches to engage
patients or service recipients, the general
public, communities, or stakeholders (such
as clinicians or payers) in the design of the
study.

90

Study parameters

22

Report all analytic inputs (such as values,
ranges, references) including uncertainty
or distributional assumptions.

91

Summary of main results

23

Report the mean values for the main
categories of costs and outcomes of
interest and summarise them in the most
appropriate overall measure.

91

Effect of uncertainty

24

Describe how uncertainty about analytic
judgments, inputs, or projections affect
findings. Report the effect of choice of
discount rate and time horizon, if
applicable.

92

Effect of engagement
with patients and others
affected by the study

25

Report on any difference patient/service
recipient, general public, community, or
stakeholder involvement made to the
approach or findings of the study

92

26

Report key findings, limitations, ethical or
equity considerations not captured, and
how these could affect patients, policy, or
practice.

96

27

Describe how the study was funded and
any role of the funder in the identification,
design, conduct, and reporting of the
analysis

n/a

Results

Discussion
Study findings,
limitations,
generalisability, and
current knowledge
Other relevant
information
Source of funding

143

Topic

Conflicts of interest

No.

28

Item

Report authors conflicts of interest
according to journal or International
Committee of Medical Journal Editors
requirements.

Appendix J: Base model variable inputs and definitions

Location
where item
is reported
n/a
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Appendix K: Two-way sensitivity analysis
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Appendix L: Multi-way sensitivity analysis
Best case scenario:

Worst case scenario:
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